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Abstract  
 
Tissue engineering of small intestine aims to provide a cure to patients 
suffering from short bowel syndrome by increasing the absorptive surface 
through neo-intestinal mucosal tissue. So far, preliminary in vivo attempts by 
a research team in the USA have shown regeneration of neo-intestinal 
mucosa in rat models with some success; however experiments in this 
complex field of tissue engineering still remain in infancy and far from clinical 
use. A fresh perspective is required to further investigate all the three 
aspects of tissue engineering, namely, the polymer scaffold, the cell supply, 
and the biomolecules. The concept of nanocomposite polymer is rapidly 
emerging and has generated a lot of enthusiasm in tissue engineering due to 
their high surface to volume ratio and hence enhanced performance. This 
work was focussed to develop and characterise scaffolds for small intestinal 
tissue engineering using a new nanocomposite polymer of polycaprolactone 
and silsesquixane, developed in our laboratory.  An in vitro study was also 
performed to test the scaffolds for cell viability and proliferation using rat’s 
intestinal epithelial cells. Our results have shown that biodegradable 
polycaprolactone-silsesquioxane nanocomposite can be fabricated in 
desired scaffold morphology using simple techniques like particulate 
leaching, and that it supports intestinal cell growth and proliferation. Future 
studies incorporating these scaffolds for in vivo use in animal models need to 
be carried out in order to investigate further about their ability to withstand 
 4 
natural forces within the abdomen, and whether they support cell growth 
based on principles of cell migration, before a more definitive and continuous 
cell supply is available in form of stem cells cued specifically to intestinal 
lineage. 
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Hypothesis 
 
Polycaprolactone-Silsesquixane nanocomposites can be fabricated in 
scaffolds with desired pore morphology and the scaffolds should support 
intestinal cell growth and proliferation when tested in vitro. 
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1.1 Clinical Problem 
 
Short-bowel syndrome (SBS) has always posed a difficult clinical problem in 
children as well as adults. Short bowel syndrome (SBS) is condition of 
nutritional malabsorption related to the surgical removal or disease of a large 
portion of the small intestine. In neonates small intestine measures around 
250 cm in length and it grows to around 750 cm in adults. In adult patients, 
small bowel length of < 100 cm is highly predictive of permanent intestinal 
failure (Messing et al. 1999). It is generally believed that a loss of more than 
70% small intestine causes SBS, which is characterised by diarrhoea, 
steatorrhoea, severe weight loss, malnutrition, and eventually failure to thrive 
resulting in a high incidence of mortality both in children and adults. The 
amount of bowel that must be lost to produce malabsorption is variable and 
depends on which section(s) is/are lost, and whether the ileocecal valve is 
preserved. It is known that patients with short bowel syndrome do better who 
have an intact ileocaecal valve and where all the colon is preserved (Mayr et 
al. 1999). 
 
The most common cause for SBS remains extensive surgical resection of 
the small intestine. Necrotising enterocolitis in neonates and Crohn’s disease 
in adults remain the most common cause for extensive surgical resection. 
Other causes include abdominal wall defects, jejunoileal atresia, midgut 
volvulus, and Hirschsprung's disease in children. Other causes in adults 
 21 
include mesenteric ischemia, neoplasms, trauma and radiation enteritis. 
Although uncommon, SBS in adults can potentially result from even 
commonly performed surgical procedures like intestinal obstruction, 
colectomy, hysterectomy and gastric bypass (Thompson et al. 2005).  
 
1.2 Current solutions to the problem of SBS 
 
The mainstay of treatment of SBS remains to improve the nutritional status 
of the patients by enteral (EN) or parenteral (PN) feeding. Home parenteral 
nutrition (HPN) has been used as a life-saving treatment for patients with 
intestinal failure. Other surgical procedures like sequential intestinal loop 
lengthening have been attempted to treat SBS but only with limited success. 
For patients dependent on PN, intestinal transplantation is the last hope in 
the present medical field. 
 
1.2.1 Parenteral Nutrition 
 
Approximately 500 patients in the U.K are treated with HPN at one time 
(British Association for Parenteral and Enteral Nutrition 2003). The estimated 
annual cost in the U.K (1995) for HPN is about £ 55 000 per patient year 
(Puntis 1998). Overall survival at one year is 92%. Some patients survive ten 
years or more with good quality of life. Less than 1% of time is spent in 
hospital once on HPN although underlying disease states often demand 
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complex care. Some patients cease to require HPN as they become able to 
return to enteral or oral nutrition due to intestinal adaptation or reconstructive 
surgery (British Association for Parenteral and Enteral Nutrition 2003). 
However, in most patients with remaining small intestine length of < 100 cm, 
dependence on PN is highly likely. The goal of treatment remains to wean off 
from this dependence. The degree of adaptation is vital in decreasing the 
dependence on parenteral nutrition and for improving patient quality of life 
and long-term outcome.  
 
Despite advancements in managing SBS such as the use of trophic factors 
to stimulate intestinal adaptation and enhance intestinal absorption, intestinal 
transplantation remains the only option for those who have developed life-
threatening complications from PN and cannot be managed using more 
conservative techniques (Jackson and Buchman 2005). Due to high 
morbidity and mortality associated with PN and intestinal transplantation, 
alternative treatment strategies have been employed in form of intestinal 
loop lengthening thus facilitating better intestinal absorption.   
 
1.2.2 Sequential intestinal lengthening procedures for SBS 
 
Techniques have been employed in the past with little success where a 
small bowel nipple valve is constructed distally to provide temporary partial 
obstruction and thereby induce dilatation and lengthening of the proximal 
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small intestine (Bianchi 1980;Georgeson et al. 1994).  
 
A recent publication describes the first successful application of tension to 
induce length and growth in rat intestine as illustrated in figure 1.1 (Jackson 
& Buchman 2005;Safford et al. 2005).  
 
 
Figure 1.1: Schematic diagram of the intestinal lengthening device (adapted with 
permission from (Chen et al. 1997;Safford et al. 2005)  
 
Chen Y et al have described a similar procedure in 1997 but they did not 
measure all the parameters of intestinal growth (Chen et al. 1997). With the 
use of an intestinal lengthening device to apply longitudinal mechanical 
tension, they have demonstrated growth of intestine in form of increased 
length by 149 %, total weight by 218 %, mucosal weight by 122 %, and 
protein mass by 164 % as compared to the controlled limb of the bowel. 
Histologically, there was a markedly increased thickness of the muscularis 
propria in the lengthened bowel (200% increase compared with the control 
limb) and functionally, increased intestinal length corresponded with 
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increased disaccharidase activity, thus implying potential increased 
absorptive capacity of the lengthened bowel. This experimental study has a 
potential to be used as an alternative treatment for SBS, but has not been 
investigated by many researchers. 
 
1.2.3 Small Bowel Transplantation 
 
Despite some success offered by surgical techniques to lengthen small 
intestine, the most promising treatment for SBS, to date, remains intestinal 
transplantation. As of 1999, 474 cases including isolated intestinal transplant, 
liver/intestinal transplant, and multivisceral transplant have been performed 
worldwide, as per the International Transplantation Registry, with 1-year 
graft and patient survival rates of 66% and 54% respectively (Kato et al. 
2002). Small bowel transplantation should be considered for all children with 
proven irreversible intestinal failure who are dependent on parenteral 
nutrition for survival (Kelly and Buckels 1995). It is important to refer children 
for small bowel transplantation as soon as hepatic dysfunction occurs or as 
soon as there are any difficulties for vascular access (Brook 1998). It is 
estimated that around 40% of patients with complete intestinal failure will 
develop liver disease by 2 years (Brook 1998). Decision to do an isolated 
intestinal transplant or combined with liver depends on the extent of liver 
damage (Beath et al. 1997). Rejection rate was significantly decreased by 
the introduction of new immunosuppressant Tacrolimus (FK506) in 1989. 
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Overall worldwide survival for isolated small bowel transplantation is around 
50% at 5 years, and for combined small bowel and liver transplantation 40% 
(Brook 1998). A study on 43 patients who received intestinal transplantation, 
showed better long-term results in those who had intestinal and multivisceral 
transplantation rather than intestinal transplantation alone (Janson 2002). 
 
1.3 Problems with current solutions to SBS 
 
There is a high mortality and morbidity associated with SBS. Most of the 
neonates with SBS die of sepsis or liver failure secondary to PN. Other 
complications include electrolyte-imbalances, bone metabolic disorders, 
catheter occlusion; catheter induced central vein thrombosis and pulmonary 
embolism. In a recent cohort study, mortality rates were as high as 37.5% in 
neonates with SBS who were on PN (Wales et al. 2005) and a recent study 
in Spain showed mortality figures in patients using HPN as high as 50% 
(Moreno et al. 2005). 
 
There are major restrictions to the rapid development of intestinal transplant 
programs due to high incidence of rejection and limited availability of donor-
organs. Many patients die while waiting for the intestinal transplant. Another 
problem is the size of the donor. A donor graft size smaller than the recipient 
is preferable especially if the recipient has undergone previous abdominal 
surgery for resection resulting in the contraction of the abdominal cavity. 
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Significant complications remain to be rejection, sepsis, and 
lymphoproliferative disease. 
 
1.4 The need for small intestine tissue engineering 
 
Like any other organ, the idea to generate an artificial small intestine would 
obviously emerge from the constant need to replace small intestine that is 
either functionally impaired or massively resected. SBS patients depend on a 
meticulous regime of nutrition for their survival. Remaining length of < 100 
cm of small intestine in adults almost inevitably results in a permanent 
intestinal failure, requiring institution of PN. Incidence of sepsis and liver 
failure from PN is significantly high. Patients who develop PN dependence 
are the best candidates for intestinal transplantation. However, high mortality 
rates of about 50% as well as shortage of donor organs limits intestinal 
transplantation to progress rapidly. The constant drive to develop tissue 
engineering has flourished because of the limitations associated with the 
alternative therapies such as Organ Transplantation or Reconstructive 
Surgery in form of limited availability of the donor organs, graft rejection and 
high costs. The availability of off-the-shelf tissues and organs would mean a 
substantial savings, being less expensive than donor organs, and would 
allow physicians to begin treatment before patients are critically ill. An off-
the-shelf artificial intestine can potentially prove to be a novel therapy for 
patients with SBS. 
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Tissue engineering is a rapidly emerging multidisciplinary area in 
biotechnology, which combines various aspects of medicine, cell and 
molecular biology, materials science and engineering, for the purpose of 
regenerating, repairing or replacing diseased tissues. 
 
Tissue engineering principles are based on the utilization of three primary 
components, namely the cell, the scaffold (whether biological or synthetic), 
and the biomolecules, which serve to integrate and to functionally regulate 
the behavior of the first two. Bioreactors play an important role in providing 
optimum in vitro physiochemical environment mimicking in vivo conditions for 
growth of tissue. 
 
Since early 1990s, almost every human tissue has been targeted for 
engineering, including parts of cardiovascular and nervous system, skin, 
eyes, liver, pancreas, muscle and intestine. To date, Bioartificial Skin is the 
most common commercially available tissue engineered biological substitute. 
Different forms of cartilage replacement have been implanted into humans 
with success, as well as bone and blood vessels.  
 
Tissue engineering of small intestine is a complex field in regenerative 
medicine. Attempts to generate neo-intestinal mucosa started in 1988 and 
some success was demonstrated by research groups in University of 
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Massachusetts, when rats’ intestinal epitheloid units were implanted in 
syngenic juvenile rats’ omentum. The scaffold used was fabricated from 
polyglycolic acid or its copolymer with polylactic acid. This generated a lot of 
enthusiasm worldwide, however due to reasons described in the next 
chapter, tissue engineered intestine remains far from clinical use.  
 
Recently the emergence of nanotechnology and concept of stem cells have 
given the field of tissue engineering a significant boost. A fresh perspective 
is required to restart investigating small intestinal tissue engineering. 
Although investigations still remain experimental, continued attempts 
worldwide especially with evolving nanotechnology, offer hope to provide an 
off-the-shelf artificial intestine as a novel therapy for patients with Short 
Bowel Syndrome. 
 
1.5 Aim of this study 
 
1. To analytically review published studies for small bowel tissue 
engineering and discuss methods adopted by different groups using 
different cell sources and polymers. 
 
2. To develop and characterise porous biodegradable scaffolds from 
nanocomposite POSS-PCL (Polyhedral oligomeric silsesquioxane-
Polycaprolactone) manufactured in our laboratory. 
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3. To grow rats’ intestinal epithelial cells onto developed scaffolds to 
study in vitro characteristics of the scaffold for future small intestinal 
tissue engineering.  
 
1.6 Layout of thesis 
 
In chapter 2, published studies on small intestinal tissue engineering are 
analytically reviewed with particular emphasis on cell source.  Achievements 
so far by researchers aimed to generate tissue engineered small intestine 
(TESI) are highlighted. Simultaneously, limitations and pitfalls are discussed 
which prevent TESI far from clinical use. In chapter 3, polymer source 
including role of nanocomposites, their properties and different methods to 
fabricate scaffolds are reviewed. Main advantages and disadvantages of 
fabricating techniques are addressed. Based on the review of literature, our 
nanocomposite polymer (POSS-PCL) is subjected to two chosen fabrication 
methods, as described in experimental chapters 5 and 6. 
  
Chapter 4 describes materials and methods used for all experiments.  
 
Results of these experiments are described in chapters 5, 6 and 7. Chapter 
5 describes formation of porous scaffolds by particulate leaching/ solvent 
casting using NaCl as the particulate. Scaffolds are characterised for their 
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porosity and pore morphology using scanning electron microscopy and micro 
CT. They are also tested for mechanical strength and chemical bond 
structure. Scaffolds made using this technique are later used for in vitro cell 
culture as described in chapter 7. 
 
In chapter 6, scaffolds developed by electrohydrodynamic atomisation using 
the same polymer (POSS-PCL) are characterised. This chapter addresses 
unsuccessful role of electrohydrodynamic spraying or spinning to form 
macro-porous scaffolds, whereas electrohydrodynamic printing to be a 
useful and potentially novel technique for obtaining pre-designed pore 
morphology.  
 
In chapter 7, cell work is described where scaffolds developed are tested for 
cell viability and proliferation. In vitro cell growth of rats’ intestinal epithelial 
cells is studied using Alamar Blue and LDH assays.  
 
Chapter 8 concludes the thesis by summarising the main achievements and 
limitations of the project. It addresses the issues associated with lack of 
progress in this complex field of tissue engineering and discusses possible 
future work.    
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Chapter 2: Critical Review of Literature – Cell Source 
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2.1 Introduction 
 
The term “tissue engineering” was officially coined at a National Science 
Foundation workshop in the United States (Georgia Tech/Emory Centre for 
the Engineering of Living Tissues) in 1988 to mean “the application of 
principles and methods of engineering and life sciences toward fundamental 
understanding of structure-function relationships in normal and pathological 
mammalian tissues and the development of biological substitutes to restore, 
maintain or improve tissue function.” (McIntire et al. 2002). 
 
Human tissue engineering is a rapidly emerging multidisciplinary area in 
biotechnology, which combines various aspects of medicine, cell and 
molecular biology, materials science and engineering, for the purpose of 
regenerating, repairing or replacing diseased tissues. Tissue engineering 
principles are based on the utilization of three primary components, namely 
the cell, the biomaterial (whether biological or synthetic), and the 
biomolecules, which serve to integrate and to functionally regulate the 
behavior of the first two.  
 
Since early 1990s, almost every human tissue has been targeted for 
engineering, including parts of the nervous system, skin, eyes, liver, 
pancreas, muscle and intestine. To date, Bioartificial Skin is the most 
common commercially available tissue engineered biological substitute. 
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Different forms of cartilage replacement have been implanted into humans 
with success, as well as bone and blood vessels.  
 
It was the same time when concept of tissue engineering was first introduced 
in 1988, that Joseph P Vacanti et al reported the generation of intestine from 
minced pieces of foetal intestine, in form of a visible 6 mm cyst, when a cell-
polymer construct was implanted into rat’s omentum (Vacanti et al. 1988). 
These results generated a lot of enthusiasm amongst researchers and an off 
the shelf intestine as a cure to short bowel syndrome could be seen as a 
viable clinical option.  
 
In our work described later in the chapters, we have aimed to address the 
biomaterial aspect of tissue engineering using a relatively new concept of 
nanotechnology. We used biodegradable nanocomposite POSS-PCL 
developed and patented in our laboratory to fabricate porous scaffolds, and 
characterized them for their suitability to be used as scaffolds for soft tissue 
engineering of structures like small intestine.  
 
As a preliminary step, we reviewed published literature to understand the 
evolution of small intestinal engineering and critically analysed the 
advancements done in this field so far against the obstacles which are 
expected in this complex field before a clinical use is likely.  
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2.2 Search Methodology 
 
A literature search was performed using keywords ‘tissue engineering’, 
‘small intestine’, ‘scaffold’, ‘stem cells’, ‘regenerative medicine’, and ‘polymer’ 
in the following databases between 1966 – 2009: Pubmed, Embase, Athens, 
Ovid online, ISI web of science, Ingenita select, Elsevier texts and Blackwell-
Synergy. 
 
2.3 Tissue engineering of small intestine 
 
It was in 1988 when the most initial attempts were made to engineer small 
intestine. This pioneering work was done by a research group in the USA 
(Vacanti et al. 1988) where a cell-polymer construct was implanted in an 
animal model (rat) to generate cyst like structures having neo-intestinal 
mucosa. 
 
An overview of tissue engineering principles is described below in figure 2.1. 
As mentioned earlier, they are based on the utilization of three primary 
components, namely the cell, the biomaterial (whether biological or 
synthetic), and the biomolecules, which serve to integrate and to functionally 
regulate the behavior of the first two.  
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Figure 2.1: Schematic diagram of overview of small intestinal tissue engineering. 
 
2.4 Cell source 
 
Cells can be differentiated or progenitor cells, adult or embryonic stem cells, 
or tissue or organ specific cells. They can be autologous, allogenic, or 
xenogenic. Attempts have been made to isolate intestinal cells from all the 
above sources, which are described below.  
 
2.4.1 From Bone Marrow - Hematopoietic stem cells 
 
Although, embryonic stem cells which are totipotent and parent all types of 
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tissue would be considered most demanding in the field of tissue 
engineering, sensitive issues like ethical and legislative issues and scarcity 
of the available embryonic cells have always driven research to continuous 
attempts finding an adult source of totipotent cells. It is believed traditionally 
that the adult stem cell differentiates only to the tissue in which it resides. For 
example, hematopoietic stem cell (HSC) would generate blood cells, liver 
progenitor cells (oval cells) would produce hepatocytes and stem cells in the 
crypts of intestinal mucosa would lead to generate intestinal cells. The 
process by which an adult stem cell can jump lineage barriers to differentiate 
into cells outside their own tissue is called Stem Cell Transdifferentiation. In 
other words this is also called lineage plasticity of adult stem cells (Korbling 
et al. 2003). The concept of transdifferentiation is one of the explanations 
why transplanted bone marrow (BM) or peripheral blood (PB) cells are 
detected in recipient solid organ specific tissues. However, the stem cell 
transdifferentiation model has also been challenged. Cell fusion has been 
postulated to be the alternative mechanism to explain the presence of BM-
derived cells in solid organ specific tissue (Korbling, Estrov, & Champlin 
2003). Apart from the HSCs that renew circulating blood cells, the adult bone 
marrow also contains mesenchymal stem cells (MSCs), which contribute to 
the regeneration of mesenchymal tissues such as bone, cartilage, muscle, 
ligament, tendon, adipose, and stroma (Pittenger et al. 1999). Bone marrow 
contains pluripotent stem cells with the potential to differentiate into mature 
cells of various organs like hepatic oval cells, hepatocytes, cholangiocytes 
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(Alison et al. 2000;Petersen et al. 1999;Theise et al. 2000), skeletal muscle 
cells (Alison et al. 2000;Ferrari et al. 1998), astrocytes, neurons (Alison et al. 
2000) and even renal tubular epithelial cells (Poulsom et al. 2001). 
 
To determine whether circulating stem cells have a similar potential Korbling 
et al concluded from a study on the biopsy specimen from liver, skin and 
gastrointestinal tract from patients with leukaemia who had undergone 
transplantation of hematopoietic stem cells from peripheral blood or bone 
marrow that circulating stem cells can differentiate into mature hepatocytes 
and epithelial cells of the skin and gastrointestinal tract (Korbling et al. 2002). 
However the exact mechanism of origin and physiological role of these cells 
is unknown. A study demonstrated a quantitative analysis of the donor 
engraftment of nonhematopoietic tissues eleven months post transplant of 
single bone marrow stem cell in mice (Krause et al. 2001). In addition to 
engraftment of columnar epithelial cells in the small bowel, donor-derived 
epithelial cells were identified throughout much of the GI tract, including the 
lining of the oesophagus, stomach, and large bowel. They demonstrated two 
patterns of epithelial engraftment of marrow-derived cells: large-scale 
repopulation in response to injury as demonstrated in liver and lung, and low 
level engraftment as individual scattered cells in the absence of marked 
injury as in liver, skin, and G.I tract. These randomly inserted single cells 
may not be fully functional since they did not appear to proliferate. Although 
little is known about how these cells obtain the degree of differentiative 
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potential, tissue-injury, local environmental signals, and recombinant human 
granulocyte colony-stimulating factor may have a significant role in the 
above process (Korbling et al. 2002;Krause et al. 2001).  
 
In the human bone marrow, the sialomucin CD34 is a hematopoietic cell 
surface antigen that has been extensively exploited for the selection of long-
term repopulating cells with multi-lineage potential, though not all HSCs 
express this marker.  
 
A study demonstrated that bone marrow cells could differentiate into human 
GI tract epithelia, and that the increase of these bone-marrow derived cells 
was closely related to the recovery from epithelial damage (Okamoto et al. 
2002). They were the first to conclude that cells derived from transplanted 
bone marrow could ‘repopulate’ every part of the human GI tract epithelia 
and contribute to the regeneration of damaged epithelial tissues.  
 
A study (Alison et al. 2000;Jiang et al. 2002) on rodent bone marrow, has 
indicated that certain mesenchymal stem cells -  termed multipotent adult 
progenitor cells (MAPCs) – differentiate, at the single cell level, not only into 
mesenchymal cells, but also cells with visceral mesoderm, neuroectoderm 
and endoderm characteristics in vitro. When injected into an early blastocyst, 
MAPCs contribute to most, if not all, somatic cell types. On transplantation 
into a non-irradiated host, MAPCs engraft and differentiate to the 
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haematopoietic lineage, in addition to the epithelium of liver, lung and gut, 
depending on the environmental cues provided by different organs. This 
technique of expansion of MAPCs in vitro and when transplanted, 
differentiation in vivo into cells of different lineages, can have a potential to 
be used into tissue engineering of small intestine in future. However, Hori Y 
and group’s attempts to generate a muscle layer failed when they seeded 
autologous mesenchymal cells onto the 5 cm tubular collagen scaffold and 
replaced it into the defect in the small intestine (Alison et al. 2000;Hori et al. 
2002). 
 
2.4.2 From peripheral blood 
 
Zhao Y et al have identified, cultured, characterised, and propagated adult 
pluripotent stem cells (PSCs) in vitro from a subset of human peripheral 
blood monocytes. They induced these cells to differentiate into mature 
macrophages by lipopolysaccharide, T lymphocytes by IL-2, epithelial cells 
by epidermal growth factor, endothelial cells by vascular endothelial cell 
growth factor, neuronal cells by nerve growth factor, and liver cells by 
hepatocyte growth factor. The pluripotent nature of these individual PSC was 
further confirmed by a clonal analysis (Zhao et al. 2003). 
 
2.4.3 Gastrointestinal stem cells (tissue specific cells) 
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Intestinal stem cells are believed to reside in the base of the crypts of 
Lieberkuhn in the small intestine as shown in figure 2.2.  
 
 
Figure 2.2: Intestinal epithelial cell generation. Putative stem cells (dark blue) reside 
immediately above the Paneth cells (yellow) near the crypt bottom. Proliferating 
progenitor cells occupy the remainder of the crypt. Differentiated cells (green) 
populate the villus, and include goblet cells, enterocytes and entero-endocrine cells. 
[Adapted with permission from (Reya and Clevers 2005)]. 
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They lie just superior to the Paneth cells (approximately the fourth or fifth cell 
position in mice) within a ‘niche’ and studies suggest that a single stem cell 
undergoes asymmetrical division to produce an identical daughter cell, and 
thus replicate itself, and a committed progenitor cell which further 
differentiates into an adult epithelial cell (Reya & Clevers 2005). 
 
There is a constant turnover of the epithelial cell lineages in the GI tract, 
increased especially in tissue injury. This process is regulated by multipotent 
stem cells, which give rise to all gastrointestinal epithelial cell lineages 
(Paneth, goblet, absorptive columnar and enteroendocrine) and can 
regenerate whole intestinal crypts (Brittan and Wright 2002).  
 
Little is known of the location and fate of the stem cells within the 
gastrointestinal tract, due to the lack of distinct stem cell markers, but they 
are usually said to appear histologically primitive and can be identified 
functionally by their ability to repopulate crypts and glands after damage 
(Brittan & Wright 2002). There are no reliable specific means to identify 
these stem cells. Musashi 1, a neural stem cell marker, is expressed in 
immature cells in the lower crypt and may prove useful as an intestinal stem 
cell marker (Kayahara et al. 2003). Recent success in identification of stem 
cells in small intestine and colon by marker gene Lgr5 may prove to be a 
vital step in isolating intestinal specific stem cells from the crypts of small 
intestine (Barker et al. 2007). Lgr5 (leucine-rich-repeat-containing G-protein-
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coupled receptor 5) is a gene selected from intestinal Wnt target genes. In 
this study, Lgr5 is found to be expressed in cycling columnar cells at the 
crypt base and when lineage-tracing experiments were performed in adult 
mice, the Lgr5 –positive crypt cell generated all epithelial lineages over a 60-
day period, suggesting that it represents the stem cell of the small intestine 
and colon. 
 
Evans et al (Evans et al. 1992) have described a reproducible method for 
growing small intestinal epithelium (from suckling rat intestine) in short-term 
cultures. Isolation of the epithelia and, significantly, preservation of its three-
dimensional integrity was achieved using a collagenase/dispase digestion 
technique. They suggested that proliferation in vitro is also critically 
dependent upon the quality of the medium and constituents used. 
 
Although the morphologic features of small intestinal epithelial progenitors 
(SiEPs) are known, their molecular features are poorly defined. Previous 
impediments to purification and molecular characterization of SiEPs include 
lack of ex vivo clonigenic assays and the difficulty of physically retrieving 
them from their niche where they are interspersed between their numerous 
differentiated Paneth cell daughters (Stappenbeck et al. 2003). In the study 
by Stappenbeck et al these cells were harvested by laser capture 
microdissection. 
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Stem cells are a small percentage of the total cellularity. In the mouse small 
intestine, there are perhaps 4-5 stem cells in a ring near the bottom of the 
crypt (Bjerknes and Cheng 1999) out of a total crypt population of about 250 
cells. 
 
2.4.4 Eneterocyte Isolation  
 
Organ et al in 1992 have reported transplantation of enterocytes (small 
intestinal epithelial cells) using cell-polymer constructs to produce 
neointestine (Organ et al. 1992). They isolated enterocytes from rat small 
intestine by using the method of Weiser (Weiser 1973) where they 
dissociated cells using citrate and obtained sequential fractions of epithelial 
cells in a villus to crypt gradient by a series of incubations and washings of 
gut loops avoiding over-manipulation. The isolated cells were seeded onto 
biodegradable polymer of PGA and enterocyte-polymer constructs were 
implanted in rats’ omentum or mesentry and also in subcutaneous plane. 
They had an overall successful engraftment in 67% cases. Their study 
indicated that enterocytes attach to synthetic biodegradable polymeric 
scaffolds, and the transplanted constructs become vascularised and remain 
viable over at least a 2-week period. This study required long-term 
histological and immunocytochemical evaluation of morphogenesis and 
function of the implants. Use of isolated enterocytes to engineer neointestine 
cannot be seen in other studies after this preliminary attempt. 
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2.4.5 Intestinal Epithelial Organoid Units 
 
After the attempted use of the enterocytes, Vacanti J.P and group moved on 
to use intestinal epithelial organoid units as the cell source to be seeded 
onto synthetic biodegradable polymer scaffolds and achieved considerable 
success in regenerating neointestinal tissue. Their laboratory was the first to 
report in 1997 making tissue engineered small intestine by the 
transplantation of organoid units on a polymer scaffold into the omentum of 
the Lewis rat (Choi and Vacanti 1997). These intestinal epithelial organoid 
units were isolated from neonatal rats as per the method first developed by 
Evans et al in 1992 for the preparation of rat intestinal epithelial cell primary 
cultures. Intestinal epithelial organoid units are multicellular units derived 
from neonatal rat intestine, containing a mesenchymal core surrounded by a 
polarized intestinal epithelium, and contain all of the cells of a full-thickness 
intestinal section (Evans et al. 1992;Weiser 1973). In this method Evans et al 
used enzymatic solution of dispase and collagenase to digest the supportive 
connective tissue thus allowing clusters of crypts and villi to be released after 
gentle pipetting. To date this method because of its surety to isolate 
intestinal stem cells has been extensively used by Vacanti JP and 
colleagues in their various experiments.  
 
In this method, the entire length of the small intestine from 6-7 days old 
 45 
neonatal Lewis rats is harvested, stripped of its mesentery, and placed in 
HBSS (Hank’s balanced salt solution) on ice. The intestines are lavaged with 
HBSS, split open, and cut into 2-3 mm fragments. Intestinal fragments are 
further washed with HBSS, sharply minced into < 1 mm3 pieces, and then 
enzymatically digested by a solution of dispase and collagenase at room 
temperature on an orbital shaking platform at 80 rpm for 25 minutes. Three 
rounds of serial agitation, sedimentation and discarding of supernatant are 
performed. The intestinal organoid units are further purified by centrifugation 
in a solution of Dulbecco’s serum, and 2% sorbitol at 300 rpm for 2 minutes. 
The resulting pellet is resuspended in medium and counted. The intestinal 
epithelial organoid units are then seeded statically onto the inner luminal 
surface of each polymer tube at a density of 4-6 × 104 organoid units per 
polymer. The organoid units are allowed to attach to the polymer for 1 hour 
before implantation (Kim et al. 1999b).    
 
2.4.6 Organoid unit-polymer construct implantation 
 
The unit-polymer constructs were wrapped with omentum after laparotomy 
and placed back in the abdominal cavity of rats. 2-3 weeks later they were 
found to develop cyst like structures and the cysts were histologically 
analysed for the characteristics of the intestinal tissue regeneration like 
presence or absence of villi, crypt width, and the thickness of the layers. The 
neointestine was also subjected to immunohistochemistry. Some studies by 
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Vacanti et al in Boston, U.S.A have shown successful formation of cysts 
between 1-8 weeks post-implantation of the organoid unit-polymer 
constructs.  
 
In most of their studies, intestinal epithelial organoid units harvested from 
neonatal Lewis rats were seeded onto biodegradable polymer tubes and 
implanted into the omentum of adult Lewis rats either implantation alone 
(group 1), implantation followed by anastomosis to native small bowel at 3 
weeks (group 2) and implantation after small bowel resection and 
anastomosis to native small bowel at 3 weeks (group 3). All constructs were 
harvested at 10 weeks and examined by histology. Morphometric analysis of 
the neomucosa was obtained using a computer image analysis program. 
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Figure 2.3 Tissue engineered intestine[(adapted from (Kim et al. 1999c)] (a) 
Photomicrograph of the tissue-engineered neointestine after anastomosis to native 
small intestine at the time of harvest (arrow indicates tissue-engineered neointestine). 
(b) Photomicrograph of the patent anastomosis between the tissue-engineered 
construct and native small intestine (bar 5 5 mm). 
 
Cyst development was noted in all animals as shown in figure 2.3. All 
anastomoses were patent at 10 weeks. Histology revealed the development 
of a vascularized tissue with a neomucosa lining the lumen of the cyst with 
invaginations resembling crypt–villus structures.  
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Morphometric analysis demonstrated significantly greater villus number, 
villus height, crypt number, crypt area, and mucosal surface length in groups 
2 and 3 compared with group 1, and significantly greater villus number, villus 
height, crypt area, and mucosal surface length in group 3 compared with 
group 2 (Kim et al. 1999c). 
 
Lymphangiogenesis in TESI was shown to develop within 8 weeks of 
implantation of organoid unit-polymer constructs by demonstration of 
increased proportion of neointestinal VEGFR-3 –positive cells and ultimately 
formation of tubular structures which resembled lymphatics architecturally, 
were distinct from CD34-positive blood vessels, and lacked luminal 
erythrocytes (Duxbury et al. 2004;Kim et al. 1999c). 
 
Kim et al in their studies have demonstrated that massive small bowel 
resection contributes significant regenerative stimuli for the heterotropically 
transplanted tissue-engineered intestine (Kim et al. 1999a;Kim et al. 1999b). 
They have also demonstrated that anastomosis between the TESI and 
native small bowel contributes significant trophic effects on neomucosal 
morphogenesis. 
 
2.5 Extracellular Matrix (ECM) 
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The extracellular matrix (ECM) consists of a complex mixture of structural 
and functional macromolecules and serves an important role in tissue and 
organ morphogenesis and in the maintenance of cell and tissue structure 
and function. It is the noncellular part of a tissue and consists of protein and 
carbohydrate structures secreted by the resident cells (Hodde 2002). The 
great diversity observed in the morphology and composition of the ECM 
contributes enormously to the properties and function of each organ and 
tissue. The ECM is also important during growth, development, and wound 
repair: its own dynamic composition acts as a reservoir for soluble signalling 
molecules and mediates signals from other sources to migrating, 
proliferating, and differentiating cells. Tissue engineering is mainly based on 
the need to provide signals to cell populations in order to promote cell 
proliferation and differentiation. These external signals  are generated from 
growth factors, cell-ECM, and cell-cell interactions, as well as from physical-
chemical and mechanical stimuli (Rosso et al. 2004). For tissue engineering 
strategies it is essential to know how cells can interact with ECM and 
transduce the information received by the extracellular molecules into an 
intracellular event. The cell surface possesses two kinds of receptors: non 
integrin and integrin receptors. There are at least two main ways by which 
the ECM can affect cell behaviour. One of these is the cell-ECM interaction 
which may directly regulate cell functions through receptor-mediated 
signalling. The other is that ECM can control the mobilization of growth or 
differentiation factors, thus modulating cell proliferation and controlling cell 
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phenotype (Taipale and Keski-Oja 1997). Tissue-engineering approaches 
typically employ exogenous three-dimensional ECMs to engineer new 
natural tissues from natural cells. The exogenous ECMs are designed to 
bring the desired cell types into contact in an appropriate three-dimensional 
environment, and also to provide mechanical support until the newly formed 
tissues are structurally stabilized and specific signals occur to guide the 
gene expression of cells forming the tissue (Putnam and Mooney 1996). In 
other terms, the template made from exogenous material to serve as ECM is 
also called a ‘scaffold’. The types of scaffolds, their fabrication methods, their 
characterisation methods and surface modification are reviewed in next 
chapter.  
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Table 2.1: Review of published studies on small bowel tissue engineering 
 
In all studies the animal model was rats except *dogs and **rabbits 
 
Study Cell 
Source 
Polymer Procedure  Outcome Pitfalls 
(Vacanti et al. 
1988) 
Isolated 
enterocyte
s 
Polyglacti
n 910, 
polyanhy
drides, 
polyortho
ester 
Cell preparations cultured 
on biodegradable 
polymers prior to 
implantion into rat 
omentum and mesentry 
3 of 23 implantations successful 
(max 6mm cyst) 
Preliminary study 
(Organ et al. 
1992) 
EC PGA  EC-polymer constructs in 
omentum, mesentery or 
subcutaneously for 2 
weeks  
Engraftment in omental and 
mesenteric but not subcutaneous. 
Stratified endothelium seen in one 
only 
Preliminary study 
using EC. Only 
mucosal cells 
regenerated  
(Organ et al. 
1993)  
Isolated 
enterocyte
s 
PGA As above compared with 
animals who had 75% 
SBR  
Engraftment lower in SBR than non-
resected group. Constructs 
vascularised and viable over a 1-
month period 
Lower 
engraftment in 
SBR group  
(Choi et al. 
1998)  
Organoid 
units 
PGA with 
PLLA +/- 
collagen  
Studied brush border 
enzymes, basement 
membrane components, 
and electrophysiology of 
TESI 
Maturation of the neointestine (2-6 
weeks). Increased villi and crypts, 
more mature columnar epithelium 
and epithelial cells with collagen 
Good results but 
requires long 
term studies 
 
 
(Kim et al. 
1999b)  
Organoid 
units 
PLLA 
coated 
PGA 
Small bowel resection, 
partial hepatectomy, and 
portacaval shunt 
compared 
Neointestinal cyst size was 
significantly greater in SBR group 
Absorbtion and 
anastomosis to 
native bowel not 
tested 
(Kim et al. 
1999c)  
Organoid 
units 
PLLA 
coated 
PGA 
Effects of anastomosis of 
TESI to native small 
bowel 
Anastomosis contributed significant 
regenerative stimuli for 
morphogenesis and differentiation 
of TESI 
Good results but 
requires long 
term studies 
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(Kaihara et 
al. 1999)  
Organoid 
units 
PLLA 
coated 
PGA 
End-to-end anastomosis 
of TESI and native small 
bowel 
Patency rate of 78% with a trophic 
effect on cyst size and neomucosa 
Lower patancy 
than side-to-side 
( 90%) with 
higher mortality  
(Chen and 
Badylak 
2001)* 
None Porcine 
SIS patch 
Defect on small bowel 
repaired with a SIS patch.   
Or resection interposed 
with tubular SIS 
Patch regenerated mucosal 
epithelial layer, some smooth 
muscle. Tubular group died due to 
leakage 
Layers not well 
organised and 
not feasible in 
longer resected 
segments 
(Perez et al. 
2002)  
Organoid 
units 
PLLA 
coated 
PGA 
Studied the immune 
system of TESI 
TESI developed an immune cells; 
dependent on exposure to the 
luminal stimuli and duration 
No evidence for 
source of cells 
(donor or host) 
(Hori et al. 
2002)* 
Autologous 
MSCs 
Collagen 
Sponge 
MSC seeded scaffold 
around silicone stent 
Mucosal layer was created Failed to 
generate muscle 
layer 
(Demirbilek 
et al. 2003)** 
None Porcine 
SIS 
SIS patch on 6cm jejunal 
defect 
Well organised mucosa and 
submucosa in 6 weeks   
Some graft 
contraction. 
Anastomosis not 
tested 
(Gardner-
Thorpe et al. 
2003)  
Organoid 
units 
PLLA 
coated 
PGA 
Angiogenesis in TESI VEGF and bFGF delivery may 
prove useful for TESI 
Further studies 
required to 
elucidate 
mechanism 
(Ramsanahie 
et al. 2003) 
Organoid 
units 
PLLA 
coated 
PGA 
Effects of GLP-2 on 
mucosal morphology and 
SGLT1 expression 
GLP-2 increased villus height and 
crypt depth and enhanced SGLT1 
expression  
Further studies 
required to 
elucidate 
mechanism 
(Tavakkoliza
deh et al. 
2003) 
Organoid 
units 
PLLA 
coated 
PGA 
Impact of luminal 
contents on epithelium, 
morphology, cellular 
dynamics and nutrient 
transporter tested 
Anastomosed neomucosa 
regenerated the SGLT1 mRNA 
expression topography of the native 
jejunum and epithelial proliferation 
higher 
Mechanism not 
studied 
 
 
(Wang et al. 
2003)  
  Rat SIS  Tubular SIS (2-cm)with 
bilateral anastomosis in  
isolated ileal loop 
Mucosa showed smooth muscle 
and serosa (24 weeks). SIS 
biocompatible, resistant to infection, 
induced neovascularisation, and 
remodelled 
Small length of 
the tubular 
segment. No re-
innervation 
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(Grikscheit et 
al. 2004) 
Organoid 
units 
PLLA 
coated 
PGA 
Studied the effect of TESI 
anastomosis on recovery 
after MSBR  
TESI anastomosis (side-to-side) 
improved postoperative weight and 
B12 absorption after MSBR 
Villin mRNA and 
IAP levels 
suggestive of 
differentiation 
were found to 
be in contrast 
 
(Duxbury et 
al. 2004)  
Organoid 
units 
PLLA 
coated 
PGA 
Studied 
lymphangiogenesis in 
TESI 
Lymphangiogenesis in submucosa 
and lamina propria by 8 weeks, 
stain positive for VEGFR-3  
Further studies 
required to 
elucidate 
mechanism 
 
(Viney et al. 
2009) 
Co-culture 
of 
established 
intestinal 
epithelial 
cell lines 
with 
fibroblasts  
Collagen 
based 
gels 
Studied in vitro 
generation of intestinal 
epithelium 
Epithelial growth achieved using 
one combination of vimentin 
expressing stromal and cytokeratin 
expressing intestinal epithelial cells 
grown on collagen gels. 
Needs trials on 
polymer 
constructs. 
(Gupta et al. 
2009) 
IEC-6 
intestinal 
epithelial 
cells 
POSS-
PCL 
Studied in vitro cell 
growth on nanocomposite 
scaffolds 
Achieved confluence of cell growth 
by day 21. Nanocomposite POSS-
PCL supports intestinal cell growth 
in vitro  
Mainly polymer 
scaffold based 
study. Needs in 
vivo trials. 
 
MSC-mesenchymal stem cell, EC-enterocytes, PGA-polyglycolic acid, PLLA-poly-L-lactic acid, SIS-small 
intestine submucosa, SBR-small bowel resection, MSBR-massive SBR, TESI-tissue engineered small intestine, 
VEGF-vascular endothelial growth factor, bFGF-basic fibroblast growth factor, GLP-2-glucagon-like peptide, 
SGLT1-Na+ -glucose cotransporter, IAP-intestinal alkaline phosphatise, VEGFR-vascular endothelial growth 
factor receptor.    
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2.6 Role of trophic factors after massive bowel resection 
 
Ray et al have studied the enterocyte nutrient transport after massive bowel 
resection when the intestine is in adaptation. They concluded from their 
study that parenteral growth hormone (GH) and epidermal growth factor 
(EGF) when given in combination for 2 weeks immediately after massive 
enterectomy synergistically enhance Na+ - dependent glutamine (GLN) 
uptake. This study emphasises the importance of the need of the growth 
factors to be considered after implantation of tissue engineered small 
intestine (Ray et al. 2003). 
 
Regulation of epithelial cell proliferation, migration and differentiation under 
physiological conditions is poorly understood. A better understanding of how 
the intestinal epithelial cells interact with their underlying basement 
membrane is required. A likely mechanism of this interaction as suggested 
through integrins, a specific subset of cell surface binding proteins (Beaulieu 
1992). It is now recognized that the basement membrane composition 
defines the necessary microenvironment required for multiple cellular 
functions during development and at maturity such as adhesion, proliferation, 
migration and cell survival as well as tissue-specific gene expression. These 
functions are themselves mediated by various cell receptors, many of which 
are members of the integrin superfamily. Integrins are transmembrane 
heterodimeric glycoproteins composed of an alpha and a beta subunit. 
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Seventeen alpha and eight beta subunits have been identified to date that 
associate to form at least twenty two different receptors. It is mainly the 
integrins belonging to the beta1 and beta4 classes that bind to basement 
membrane molecules such as the laminins and the type IV collagens 
(Beaulieu 1992). 
 
2.7 Discussion 
 
Stem cells have played a pivotal role in tissue engineering of small intestine. 
Out of the three main sources - haematopoietic stem cells from the 
peripheral blood, mesenchymal stem cells from the bone marrow, and tissue 
specific stem cells from intestinal crypts, the later has proved to be the only 
successful cell source in generating near-normal intestinal tissue. Unlike the 
MSCs and HSCs, intestinal stem cells almost guarantee the regeneration of 
all types of intestinal cells (absorptive-columnar, goblet, Paneth and 
autoendocrine cells), including muscle cells. Although HSCs from the 
peripheral blood have been shown to engraft in the gut lining when 
leukaemia patients received transplantation of haematopoietic stem cells 
from peripheral blood, the exact mechanism of origin and physiological role 
of these cells is unknown (Korbling, Estrov, & Champlin 2003). A low level 
engraftment was seen as individual scattered cells. These randomly inserted 
single cells may not be fully functional since they did not appear to proliferate. 
Although little is known about how these cells obtain the degree of 
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differentiative potential, tissue-injury, local environmental signals, and 
recombinant human granulocyte colony-stimulating factor may have a 
significant role in the above process (Korbling, Estrov, & Champlin 
2003;Krause et al. 2001). In another study Zhao et al successfully 
demonstrated fibroblasts like macrophages (f-Mφ) derived from monocyte-
rich samples of peripheral blood to show their ability to mature into epithelial 
cells when treated with Epidermal Growth Factor (EGF), and cells of other 
lineages when exposed to the respective growth factors. These cells have a 
potential for tissue repair and regeneration but their use in small intestinal 
tissue engineering has not been attempted so far. Can these PSCs be used 
in vitro to seed the polymer, will it generate all the layers of bowel wall, are 
there enough and appropriate growth factors available, these are some of 
the questions which remain unanswered. More knowledge about growth 
factors, cell markers, optimum culture medium, and their exact function is 
required before they can be experimented in tissue engineering of small 
intestine.  
 
Adult bone marrow stem cells have many characteristics which make them 
suitable for their potential use in tissue engineering of small intestine, like 
they can replicate as undifferentiated cells that have the potential to 
differentiate into lineages of mesenchymal tissues, they display a stable 
phenotype, they are immunocompatible, and they have no ethical issues. 
However, there are a number of technical obstacles, such as how to isolate 
 57 
stem cell preparations without contamination by other cells, how to control 
the permanent differentiation to the desired cell types, and how to increase 
the production of the large number of cells needed to create tissues (Shieh 
and Vacanti 2005). Bone marrow-derived cells or the cells from circulating 
stem cells (peripheral blood) although have a great potential to be used as a 
source for organ reconstitution and repair, to date no one has successfully 
used them in the field of small intestine tissue engineering. Lack of 
mechanism of differentiation, paucity of these cells (Krause et al found an 
extremely small number of bone marrow-derived epithelial cells in the lung, 
bile duct and G.I tract of mice transplanted with a single bone marrow 
hematopoietic stem cell) and lack of recognised function of these cells have 
restricted their use in tissue engineering of small intestine. 
 
Hori et al in 2001 did succeed in regenerating intestinal tissue on the luminal 
surface of the collagen scaffold seeded by autologous MSCs which they 
applied to replace a 5 cm defect in the dog jejunum. However they failed to 
generate a muscle layer, which is essential for functional peristalsis. 
Presence of mucosal layer was evident in the neointestinal tissue as also 
described in their previous study on dogs where they replaced an 
intrathoracic oesophageal segment of 5 cm by collagen scaffold alone 
wrapped around a silicone tube without being seeded by MSCs (Yamamoto 
et al. 1999). Clearly, the presence of mucosal layer in both their studies 
appears to come from migration of epithelial cells from the surrounding 
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healthy intestinal mucosa. But the mechanism of cell-migration to generate a 
mucosal layer cannot be relied upon where a much longer intestinal scaffold 
is required to replace small intestine with an aim to treat short bowel 
syndrome. As suggested by them, the failure of muscle layer regeneration 
might be due to various reasons. First, the number of seeded cells could be 
inadequate, or expansion of MSCs on the scaffold ex vivo might be required 
before implantation, second possibility is that preconditioning of MSCs by 
some additional directional stimulus for differentiation into muscle might be 
necessary before implantation. Hence, as suggested by them, advancement 
in use of trophic factors with the MSCs like basic fibroblast growth factor or 
vascular endothelial growth factor may be effective in regenerating highly 
differentiated and organised intestinal tissue including muscle layer. It might 
be necessary to supplement the neointestinal implantation with the 
parenteral administration of trophic growth factors to improve the enterocyte 
nutrient transport as suggested by studies.  
 
Clearly, intestinal stem cells remain the most valid option as the cell-source 
because of their ability to differentiate in all types of intestinal cells. Isolation 
of only stem cells from intestinal crypts poses a great difficulty due to lack of 
specific stem cell markers and also difficulty in physically retrieving them 
from their niche where they are interspersed between their numerous 
differentiated Paneth cell daughters. Laser capture microdissection 
technique has been used with little success to harvest these cells. Another 
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priority should be the development of robust in vitro culture systems for the 
intestinal epithelium (Bjerknes and Cheng 2005). 
 
Use of intestinal epithelial organoid units by Vacanti and group since 1997 
has proved to be a successful method in providing the cell source. These 
units of < 1 mm3 pieces of minced neonatal rat intestine are prepared by 
enzymatic digestion (as described earlier in this article) containing all of the 
cells of a full thickness intestinal section. 
 
Regulation of epithelial cell proliferation, migration and differentiation under 
physiological conditions is poorly understood. A better understanding of how 
the intestinal epithelial cells interact with their underlying basement 
membrane is required. A likely mechanism of this interaction, as discussed 
before, is through integrins, a specific subset of cell surface binding proteins.  
 
Apparently, much work is needed in the field of cell-ECM interactions, 
specific stem cell markers, and trophic growth factors. Advancements in 
developing larger absorptive surface area of the TESI with formation of a 
better muscular layer would prove to be a very successful step forward. 
 
Tissue engineering of small bowel remains at an early stage. The absorptive 
capacity is yet to be adequately tested in any constructs and current 
methods would provide insufficient cells for clinical applications.  The use of 
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organoid units suggests that mucosal stem cells are useful in the generation 
of mature mucosa in TESI. Studies on rats have shown that large numbers 
of such units are needed to produce short lengths of TE construct.  The 
isolation of the stem cells from these units or the use of stem cells from other 
sources, such as the MSC from the bone marrow, may provide a clinical 
alternative to the organoid units. In vitro culture of these cells is likely to be 
necessary to obtain clinically useful numbers of such cells. 
 
The use of cultured stem cells and improved polymer technology provide the 
most likely future for TESI.  Peptides other than collagen like fibronectin or 
self assembling hydrogels bound to the polymers have been shown to be 
useful in bone, cartilage, and cardiovascular tissue engineering and provide 
further hope for tissue engineered small intestine. 
 
A more definitive and continuous cell supply will be needed to maintain the 
generated absorptive surface in form of neo-intestine. Stem cells cued 
specifically to intestinal lineage offer promise to fulfil the high demand of 
continuous cell source. While awaiting the specific cell markers available 
which can be targeted for small intestinal lineage, an ideal scaffold needs to 
be prepared incorporating vital features of appropriate physical and chemical 
characteristics. Recently nanocomposite scaffolds have shown many 
advantages in tissue engineering due to their high surface to volume ratio. 
Our aim in this study has been to develop and characterise scaffolds for 
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small intestinal tissue engineering using a new nanocomposite of 
polycaprolactone and silsesquixane, developed in our laboratory.  An in vitro 
study was also performed to test the scaffolds for cell viability and 
proliferation using rat’s intestinal epithelial cells. Future studies incorporating 
these scaffolds for in vivo use in animal models will need to be carried out in 
order to investigate further about their ability to withstand natural forces 
within the abdomen, and whether they support cell growth based on 
principles of cell migration. 
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Scaffolds design is complex, and various parameters need to be addressed 
when fabricating a scaffold such as the material used, the fabrication 
technique, pore morphology and porosity, mechanical strength, 
biocompatibility, surface properties, degradation rate, and degradation 
products. There is not a ‘universal’ ideal scaffold, and design of a particular 
scaffold needs to be tailored according to the specific application in question. 
Scaffolds’ main function is to provide support to the growing cells until the 
extra cellular matrix produced by cells take over the degrading scaffold 
material. An ideal scaffold should be easy to fabricate and mould in the 
desired shape. It should be strong enough to withstand forces in vivo and in 
vitro until the tissue has grown. It should not provoke inflammatory response, 
and should be sterilizable. It should have a controlled porous structure, and 
should be resorbable. 
 
In this chapter, we review physical and chemical properties required in 
development of a scaffolds. We also review advantages and disadvantages 
of different methods used in literature to develop scaffolds. 
 
Based on the source of material, a scaffold can be classified as: 
• Natural 
o Small intestinal submucosa (SIS) 
o Collagen 
o Acellular dermis 
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o Amniotic membrane tissue 
o Cadaveric fascia 
o Bladder acellular matrix 
• Synthetic – Polymers 
o  Polyglycolic acid (PGA) 
o Poly(L-lactic acid) (PLLA) 
o Copolymer poly(D,L-lactic co-glycolic acid) (PLGA) 
o Polycaprolactone (PCL) 
 
3.1 Natural scaffold 
 
The naturally occurring scaffolds can be processed in such a way as to 
retain growth factors, such as basic fibroblast growth factor (FGF-2) and 
transforming growth factor-beta (TGF-β) (Voytik-Harbin et al. 1997), 
glycosaminoglycans, such as heparin and dermatan sulphate and structural 
elements, such as fibronectin, elastin and collagen. These material prevent 
many of the complications associated with foreign material implants because 
they provide a natural environment onto which cells can attach and migrate, 
within which they can proliferate and differentiate (Hodde 2002). 
 
3.1.1 Small Intestinal Submucosa (SIS)  
 
Small intestinal submucosa (SIS) is a naturally occurring, acellular 
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xenogenic biomaterial that has been used extensively as a soft tissue 
replacement, as a scaffold for tissue engineering, and as a substrate for the 
study of cells in 3D culture. It is mainly derived from porcine small intestine 
but other mammals like rats and dogs have also been used. The presence of 
above mentioned properties of a natural scaffold made it available to be 
used in a variety of clinical conditions including vascular grafts like inferior 
vena cava grafts, duodenal patches, tendon repair, repair of meniscal 
defects, as bladder neck strings for urinary incontinence, abdominal wall 
defect repair, in ophthalmic surgery and as a scaffold for experimental tissue 
regeneration like intestinal cells and dermal fibroblasts. SIS consists of three 
distinct layers: the lamina propria and muscularis mucosae of the intestinal 
mucosa, and the tunica submucosa (Hodde 2002). The tunica submucosa is 
the layer of connective tissue arranged immediately under the mucosal layer 
of the intestine and is a 100-200 µm thick interstitial ECM; it makes up the 
bulk of the SIS biopolymer scaffold (Hodde 2002). SIS is harvested from the 
mammalian small intestine by mechanically separating it fom its outer 
muscular layers and internal mucosal layers. The biopolymer is thoroughly 
rinsed in water, treated with an aqueous solution of 0.1% peracetic acid, and 
rinsed in sequential exchanges of water phosphate buffered saline to yield a 
neutral pH. It is then either stored in an antibiotic solution containing 0.05% 
gentamicin sulphate, or sterilized using 2.5-mRad gamma irradiation 
(Badylak et al. 2000). When SIS is implanted as a naturally occurring 
biopolymer scaffold, it stimulates angiogenesis, connective and epithelial 
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tissue growth and differentiation, as well as deposition, organisation, and 
maturation of ECM components that are functionally and histologically 
appropriate to the site of implantation (Badylak et al. 2000). SIS comprises 
primarily of fibrillar collagens and adhesive glycoproteins which serve as a 
scaffold into which cells can migrate and multiply. In the whole, unprocessed 
intestine, the SIS layers also contain potent regulatory factors, such as 
glycosaminoglycans, proteoglycans, and growth factors, which regulate 
cellular processes that maintain tissue homeostasis and respond to injury 
and infection. Many of these components are retained in the biopolymer 
scaffold following processing (Hodde 2002). 
 
Demirbilek et al (Demirbilek et al. 2003) studied the effect of porcine SIS as 
a xenogenic material used in intestinal regeneration when used to repair the 
created jejunal defect in rabbits. They demonstrated a remarkable 
regeneration of complete intestinal mucosa at 6 weeks with evidence of 
fibroplasias, angiogenesis, and mild mononuclear cell infiltration. 
 
3.1.2 Collagen Scaffold 
 
Hori Y et al reported successful tissue engineering of small intestine in a 
study on dogs when they used ‘acellular’ collagen sponge scaffold grafting 
with a silicon tube stent (Hori et al. 2001) (figure 3.1). 
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Figure 3.1: Schematic drawings of the operative procedure using collagen sponge. A 
silicone tube stent was inserted and fixed by sutures. A collagen sponge scaffold was 
then applied to wrap across over the gap. Finally, the scaffold was wrapped with 
omentum (redrawn with permission from Hori et al. 2002). 
 
 
In their study collagen scaffold worked as a kind of extracellular matrix for 
tissue regeneration. According to them, if the conditions on the scaffold are 
able to support tissue regeneration, then the required host cells migrate onto 
the scaffold and the tissue regenerates at its own site. The length of the graft 
used was 5cm long. We cannot however say with confidence whether similar 
migration of the adjacent cells would occur to regenerate tissue if much 
longer segments of the small intestine are resected and replaced with 
acellular sponge scaffolds. Another drawback in their study was that proper 
thick muscle layer essential for functional peristalsis was not observed. Also, 
mucosal function for nutrient absorption was not evaluated and stenosis of 
the regenerated intestine was observed in some cases (Hori et al. 2001). 
 
3.2 Synthetic scaffold 
  
In the field of tissue engineering of small intestine so far, the most commonly 
used scaffold has been the biodegradable polymer made of polyglycolic acid. 
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Vacanti and colleagues have pioneered the arena of small intestinal tissue 
engineering by using a highly porous, synthetic, biodegradable polymer 
tubes fabricated from nonwowen sheets of polyglycolic acid (PGA) fibres 
marketed from Smith and Nephew, Heslington, York, U.K. Mooney et al in 
their study on biomaterials have emphasised the role of poly(L-lactic acid) 
(PLLA) and a 50/50 copolymer poly(D,L-lactic-co-glycolic acid) (PLGA) in 
stabilizing PGA meshes to form three dimensional structures like tubes when 
sprayed over PGA meshes. They showed that PGA meshes when sprayed 
with PLLA or PLGA were capable of withstanding large compressive forces 
in vitro (50-200 mN) and maintained their structure in vivo when implanted 
into the omentum in rats (Mooney et al. 1996b).  
 
3.2.1 Scaffold fabrication 
 
Highly porous, synthetic, biodegradable polymer tubes were fabricated from 
nonwoven sheets of PGA fibres as described by Mooney et al. Vacanti and 
colleagues in most of their experiments used a 15 × 10 mm rectangle of 
PGA mesh with a fibre diameter of 5 µm, mesh thickness of 2 mm, bulk 
density of 60 mg/cm3, porosity of 95% and a mean pore size of 250 µm. This 
piece of mesh was wrapped around a Teflon cylinder to form a tube and the 
overlapping ends were manually interlocked to form a seam. The Teflon 
cylinder was then rotated at 20 rpm using a stirrer. A solution of poly-L-lactic 
acid (PLLA) dissolved in 5% w/v chloroform was placed in an atomizer and 
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sprayed over the polymer tube for 10 seconds. After spraying was completed, 
the solvent was allowed to evaporate and the polymer tubes were lyophilized 
for 48 hr to remove residual solvent. The polymer tubes were cold gas-
sterilized with ethylene oxide and then coated with 600 µg/polymer collagen 
type I overnight. The collagen-coated polymer tubes were subsequently 
washed three times with HBSS before seeding (Kim et al. 1999b).   
 
Poly(D,L-lactide-co-glycolide) (PLGA), a biodegradable synthetic polymer, is 
widely used in a variety of tissue-engineered applications, including drug-
delivery systems. In a study the polymer has also been impregnated with 
SIS to develop (SIS/PLGA) hybrid. Fabrication parameters, including ratios 
of SIS, PLGA and salt, were optimized to produce the desired macroporous 
foam. The scaffolds had a relatively homogeneous pore structure, good 
interconnected pores from the surface to core region and showed an 
average pore size in the range 69-105 micron and over 90% porosity. The 
SIS/PLGA scaffolds degraded with a rate depending on the contents of the 
SIS. After the fabrication of the SIS/PLGA hybrid scaffolds the wettability of 
the scaffold was greatly enhanced, resulting in uniform cell seeding and 
distribution. So, it was observed that cell attachment to the SIS/PLGA 
scaffolds increased gradually with increasing SIS contents (Lee et al. 2004). 
 
3.2.2 Nanocomposites 
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Nanocomposites are new generation of polymer used for development of 
tissue and organ engineering. So far only PLGA or PGA alone has been 
predominantly experimented for small intestinal tissue engineering. Although 
mainly due to lack of constant cell source supply, investigations into small 
intestinal tissue engineering have ceased moving. As a fresh perspective we 
intend to use our house made relatively new nanocomposite. Our laboratory 
has developed a biodegradable nanocomposite by incorporating the 
biostable POSS nanocages into a poly(caprolactone/carbonate)urethane 
urea. Nanocomposites can be defined as multiphase solid materials where 
one of the phases has a dimension of less than 100 nanometres (nm) 
(Ajayan et al. 2003;Kannan et al. 2005). Our nanocomposite is made of 
polyhedral oligomeric silsesquixane (POSS) and polycaprolactone (PCL). 
POSS molecules are 6 nm in size. Studies on biodegradation of this polymer 
have been done separately (Raghunath et al. 2008). The nanocages provide 
a ‘‘shielding effect’’ on the soft phase of the polymer. Polycaprolactone is 
degradable aliphatic polyester which has been extensively reported to 
demonstrate biocompatibility in vivo. Its degradation by hydrolysis and 
enzymes is well documented. PCL has been used in several copolymers and 
polymer blends as the foundation to a tailor-made polymer with specific 
properties. In vivo host response of POSS-PCL has not been studied but 
POSS-PCU, the nonbiodegradable counterpart lacking polycaprolactone, 
made by the same group, was implanted in sheep for 36 months and 
showed only minimal inflammation as compared to silicone implants 
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(Kannan et al. 2007).   It is proposed that caprolactone will provide controlled 
degradation whilst the POSS nanocages will contribute to the mechanical 
strength required for a tissue engineering scaffold for soft tissue such as 
small intestine.  
 
Scaffolds need to be pliable for soft tissue engineering especially when 
tubular structures are required like in vascular or intestinal tissue engineering. 
Both PGA and PLA are crystalline polymers and PGA has higher crystallinity 
than PLA. We fabricated pure PGA and PLA macroporous scaffolds using 
simple salt leaching techniques but the scaffolds damaged macroscopically 
when attempts were made to roll the sheets into tubular structures. Studies 
have shown that blending PGA, PLA or their copolymers with substances 
like PEG have resulted into the desired pliability (Wake et al. 1996). 
 
Another disadvantage to fabricate PGA into scaffolds is its peculiar solubility 
in only very highly fluorinated organic solvents like hexafluoroisopropanol, 
whereas other biodegradable polymers like PLLA and PCL are soluble in 
most of the common organic solvents like chloroform, methylene chloride, 
DMAC, etc. 
 
3.3 Scaffold Properties 
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3.3.1 Biodegradable vs Nonbiodegradable 
 
Biodegradation mainly occurs through chemical hydrolysis although other 
mechanisms like oxidation or per-oxidation may be responsible for 
degradation as well. Combining chemical groups such as esters, anhydrides 
and amides add to hydrolytic instability of the polymers and hence aid 
biodegradation.  Homogenous bulk erosion involves diffusion of water into 
the polymer bulk. If degradation is faster than the diffusing water, diffusing 
water gets absorbed quickly by hydrolysis inhibiting water reaching the bulk 
of the polymer, and the degradation occurs only on the surface of the 
polymer, known as heterogenous surface erosion. Usually biodegradation of 
polymer scaffolds is a combination of both bulk and surface erosion (Voytik-
Harbin et al. 1997). Degradation depends on chemical and physical 
properties such as molecular weight, crystallinity, porosity, hydrophilicity, and 
surface to volume ratio. 
Scaffold Biodegradable Biocompatible 
Hydrophilic 
Porous 
Mechanical strength 
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Figure 3.2: Optimal relationship between matrix formation and scaffold degradation 
 
Biodegradable polymers have now been universally accepted as material of 
choice for scaffolds to be used in the purpose of tissue engineering. The 
rationale behind this is their disappearance from the implanted site as new 
engineered tissue (matrix) begins to form, thus reducing chances of 
extrusion and foreign body reaction. It is also believed that the newly 
generating tissue needs room to grow and expand and this can be inhibited 
by the presence of remaining scaffold material. The material should degrade 
into non-toxic products allowing neo-tissue to survive.  
 
Non-biodegradable material like metals and ceramics are still widely used for 
surgical implants, particularly in orthopaedic applications like hip prosthesis, 
despite their limited processability (Yang et al. 2001). Ceramic implants for 
osteogenesis are based mainly on hydroxyapatite for its inorganicity. The 
usual fabrication technique for ceramic implants is sintering of ceramic 
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powders at high temperatures (Karageorgiou and Kaplan 2005). Other 
ceramics include bioglass having different compositions of SiO2, CaO, Na2O, 
and P2O5.  Biodegradable bioceramics such as α-tricalcium phosphate, β-
tricalcium phosphate have received significant attention due to their 
biodegradation and easy processability. Particularly, in bone tissue 
engineering, composites of biopolymer with bioactive ceramic or glass are 
believed to provide – (a) better cell seeding and growth environment due to 
good osteoconductivity properties provided by the bioactive phase, (b) 
buffering effect to the acidic degradation by-products of polyesters, and (c) 
better mechanical properties owing to stiffer particulates in form of ceramics 
(Boccaccini and Blaker 2005). In bone tissue engineering, where mechanical 
strength of the implants is crucial, metals have been the materials of choice 
as the bulk phase of the implants, while titanium particle coatings create a 
porous surface.   
 
In soft tissue engineering, biomaterials used for fabricating scaffolds have 
mostly been biodegradable. Biodegradable polymers can be natural like 
collagen, SIS (small intestinal submucosa) or fibrin, or they can be synthetic 
such as polyglycolic acid (PGA), poly L-lactic acid (PLLA), copolymer poly 
D,L-lactic-co-glycolic acid (PLGA) or polycaprolactone (PCL). Synthetic 
polymers in general are much favoured over natural ones as they can be 
modified in terms of physical and chemical properties in order to obtain tailor 
made scaffolds, and they are more reliable source of raw material. 
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In this study, we use our laboratory made biodegradable nanocomposite of 
polyhedral oligomeric poly (carbonate-urea)-silsesquioxane and 
polycaprolactone (POSS-PCL) wherein we have incorporated the biostable 
POSS nanocages into a poly(caprolactone/carbonate)urethane urea. It is a 
polyurethane with a soft segment composed of polycaprolactone (80%) and 
polycarbonate (20%) and a urea hard segment. The polymer is ~22% by wt 
hard segment. This formula is the first of a series of biodegradable 
nanocomposites being developed by our department for use in tissue 
engineering for a variety of tissue types. Eighty percentage of 
polycaprolactone diol (mwt) was considered an appropriate initial formula for 
use as a tissue engineering scaffold for small intestine. Such a scaffold 
would be required to maintain its structural integrity for at least 4–6 months. 
It is proposed that caprolactone will provide controlled degradation whilst the 
POSS nanocages will contribute to the mechanical strength required for a 
tissue engineering scaffold for soft tissue such as small intestine.  
 
This composite has been tested for degradation in a separate study 
(Raghunath et al. 2008). The nanocomposite (POSS-PCL) was exposed to a 
selection of degradative solutions for up to 8 weeks. The samples were 
analyzed by infra-red spectroscopy, scanning electron microscopy, X-ray 
microanalysis, contact angle analysis, and stress-strain mechanical analysis. 
Degradation of hard and soft segments of the nanocomposite was evident by 
infra-red spectroscopy in all conditioned samples. POSS nanocage 
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degradation was evident in some oxidative/peroxidative systems 
accompanied by gross changes in surface topography and significant 
changes in mechanical properties. The hydrophobic polymer became more 
hydrophilic in all conditions. This biodegradable nanocomposite 
demonstrated steady degradation with protection of mechanical properties 
when exposed to hydrolytic enzymes and plasma protein fractions and 
exhibited more dramatic degradation by oxidation. However it has not been 
clear from this study that how long will this composite take to degrade. It is 
assumed that it may take approximately 6 months for 50% degradation, 
based on other studies on degradation of PCL without POSS. 
 
3.3.2 Hydrophobic versus Hydrophilic and Surface Modification 
 
Usually, scaffolds fabricated have a hydrophobic surface unless 
hydrophillised by adding agents like polyvinyl alcohol (PVA), polyethylene 
glycol (PEG), polyethylene oxide, etc. When polyuethanes are added with 
agents like polyethylene oxide, they become highly hydrophilic materials. 
With increasing polyethylene oxide content, the composite can act as 
hydrogels, absorbing a lot of water. A balance between the hydrophilicity and 
hydrophobicity of polymers is sometimes needed to enhance biocompatibility. 
Our POSS-PCL composite when was subjected to degradative solutions, the 
hydrophobic polymer became more hydrophilic (Raghunath et al. 2008).  
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Most of the biodegradable synthetic polymers (like PGA and PLA) are 
hydrophobic and may require modifications on their surface for better cell 
attachment. This can be achieved by surface coating, chemical coating, 
plasma treatment, or modifying the fabrication of scaffold itself (Wang et al. 
2005c). A rough than a smooth fibre surface is favourable for cell attachment. 
Nanopatterning of biomaterial surfaces has been used as surface 
modification strategy to enhance protein activities, cellular functions and 
tissue responses. Coating the surface with extracellular matrix (ECM) 
proteins such as fibronectin, vitronectin, and collagen, provides an adhesive 
interface between the polymer scaffold surface and cells that resemble the 
native cellular milieu. It is one of the simplest surface modification methods. 
The cell-binding domain of fibronectin, vetronectin and collagen contains the 
tripeptide RGD (Arg-Gly-Asp) (Wang et al. 2005c). Stem cells from adipose 
tissue are found to attach better to scaffolds coated with peptide sequences 
derived from ECM laminin (Santiago et al. 2006). Surface modification is 
described in section 3.5. 
 
3.3.3 Biocompatibility  
 
Apart from biodegradable, the scaffold material has to be biocompatible as 
well, i.e., it has to allow cell growth and proliferation, and when implanted in 
vivo, should not lead to unwanted tissue response. Biocompatibility of a 
polymer can be assessed by in vitro tests before the material can be tested 
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in animal models. Toxic material is released in culture medium when cells 
are grown onto the polymer scaffold due to incorporation of toxic organic 
solvents. Cytotoxicity depends on manufacturing process of a polymer. 
Repeated washing of the culture medium is recommended in order to avoid 
cell death. The surface modification techniques described above also help 
promote the biocompatibility by enhancing cell-cell and cell-polymer 
interactions. We report cell culture results to test the biocompatibility of our 
polymer composite POSS-PCL in the chapter 7.  
 
3.3.4 Porosity 
 
Pores in the scaffolds play a vital role in the tissue generation. 
Interconnected pores are required for infiltration of the cells into scaffold, and 
to facilitate the exchange of nutrients and cellular waste products (Hou et al. 
2003). Pore size requirements differ in different applications, for example, 
the minimum pore size required to regenerate mineralized bone is generally 
considered to be ~ 100 µm (Hulbert et al. 1970;Karageorgiou & Kaplan 
2005); and for soft tissue engineering like small intestine, pore size widely 
used has been in the range of 250 µm (Kaihara et al. 1999;Kim et al. 1999c). 
Whereas on one hand pore size >50 µm facilitate better nutrient and cell 
transport, on the other hand micropores in sizes around <20 µm are 
responsible for a greater surface area for protein adsorption, better ionic 
solubility in the microenvironment and cell attachment. In literature it has 
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also been shown that a combination of macro- and micro-pores have 
resulted in better drug delivery, strength and stiffness particularly in bone 
tissue engineering, as compared to non-microporous scaffolds (Hing et al. 
2005;Woodard et al. 2007). The pore interconnectivity is also important in 
removing cellular waste products as well as facilitating neo-vascularisation 
within the scaffold to supply the new generating tissue. Pore interconnectivity 
is known to influence fluid permeation, cell migration, and tissue ingrowth. 
Optimizing pore size and interconnectivity poses a great challenge in tissue 
engineering and there is little information in the literature about the ‘ideal’ 
pore size and interconnectivity for various tissue engineering applications. In 
one of the studies, NaCl particles have been fused by subjecting them to 
95% humidity prior to processing them in order to obtain better pore-
interconnectivity (Murphy et al. 2002).  
 
3.3.5 Mechanical Strength 
 
Another factor in scaffold manufacturing is mechanical strength so that the 
scaffolds should be able to bear the stress load after implantation. Increased 
porosity and pore size in a scaffold should ideally result in increased tissue 
growth however it does compromise the mechanical strength of the scaffold. 
Although increased porosity and pore size facilitate tissue genesis, they 
result in reduction of mechanical properties of the scaffold due to change in 
its structural integrity. In a study on scaffold design (Hollister 2005), it is 
 80 
shown that increasing the amount of material increases elastic properties 
while decreasing permeability for a particular scaffold design; however, for a 
given porosity, different scaffold microstructures will lead to different effective 
stiffness and permeability. The same study also shows that permeability 
decreases as expected with volume fraction and that for a given volume 
fraction the cylindrical pore design is more permeable.        
 
Scaffolds need to be pliable for soft tissue engineering especially when 
tubular structures are required like in vascular or intestinal tissue engineering. 
Both PGA and PLA are crystalline polymers and PGA has higher crystallinity 
than PLA. We fabricated pure PGA and PLA macroporous scaffolds using 
simple salt leaching techniques but the scaffolds damaged macroscopically 
when attempts were made to roll the sheets into tubular structures. Studies 
have shown that blending PGA, PLA or their copolymers with substances 
like PEG have resulted into the desired pliability (Wake, Gupta, & Mikos 
1996). 
 
3.4 Fabrication Methods 
 
3.4.1 Particulate Leaching 
 
The solvent casting/ particulate leaching method is a simple and inexpensive 
way to fabricate scaffolds. In this technique, water soluble salt particles are 
mixed into a biopolymer solution. The mixture is then cast into the desired 
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shape mould and the solvent is removed by evaporation, or vacuum drying 
and lyophilisation (Liao et al. 2002).  
 
Table 3.1: Main Scaffold Fabrication Techniques 
Technique 
 
 
Main Advantages Pitfalls 
Particulate 
leaching/Solvent 
casting 
Simple, inexpensive, Controlled 
pore size and porosity.  
Irregularity of pores, 
repeatability less precise, 
residual particulate matter, 
toxic organic solvents, time 
consuming, limited scaffold 
thickness, limited to 2D 
structures, inability to 
incorporate protein based 
growth factors while 
processing. 
Compression Molding Better control of scaffold thickness 
and surface uniformity. 
Thermal degradation of the 
polymer can occur. 
Freeze drying Avoids an extra step of 
washing/leaching, pore size can 
be increased by increasing 
polymer Mw and volume fraction 
of dispersed phase. 
Pore morphology highly 
dependent on parameters 
like emulsion viscosity, 
polymer wt% and polymer 
Mw. Small pore size. 
Phase separation/ 
Emulsification 
Allows incorporation of bioactive 
agents. Does not require an extra 
leaching step 
Inability to form large pores. 
Need of organic solvent. 
Gas foaming Avoidance of residual organic 
solvents/ or high temperatures.   
Usually closed pore structure 
Fibre Bonding High porosity with interconnected 
pores, easy process 
Presence of organic solvents 
could be toxic. May need 
several hours of vacuum 
drying before usable. Cells 
likely to be damaged if 
seeded during processing of 
scaffold. 
Electrospraying & 
Electrospinning 
Can produce ultrafine fibres in 
range of nanometers. 
Limited thickness of 
scaffolds, less porosity. 
Rapid Prototyping/ 
Solid freeform 
fabrication. 
3 D printing or Direct 
Writing   
Highly reproducible architecture. 
Precise control over pore-
morphology and mechanical 
properties. Solvent-free and 
Porogen-free systems. Can 
include bioactive components like 
cells, growth factors and drugs 
during fabrication. 
Expensive,  
Sophisticated equipment 
required, Relatively less 
porosity obtained as 
compared to the conventional 
techniques (~80%) 
Extrusion/ Injection 
moulding 
Straightforward technique for solid 
implants 
Difficult to fabricate pliable 
scaffolds needing high 
porosity 
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The water soluble salt particles are then leached out with water to leave a 
porous structure. Sodium chloride is the most commonly used salt, however 
other salts such as ammonium bicarbonate has also been used, which 
worked as an efficient gas foaming agent as well as a particulate porogen 
salt (Nam et al. 2000). Other salts include sodium citrate and sodium tartrate. 
In reported studies (Mikos et al. 1994), when 70-90 wt% salt was used, the 
membranes were homogeneous with interconnected pores. The membrane 
properties were independent of the salt type and were only related to the salt 
weight fraction and particle size. The porosity increased with the salt weight 
fraction, and the median pore diameter increased as the salt particle size 
increased. The advantages and disadvantages of this technique are well 
described in studies (Liao et al. 2002). As the amount and size of the salt 
particles can be adjusted, this technique offers an adequate control of the 
pore size and porosity of the scaffold. However, the distribution of the 
soluble salt is not uniform within the polymer solution, because of the 
difference between the density of the liquid polymer solution and that of the 
solid salt. Another problem often encountered is the complete wrapping of 
the salt particles by the polymer solution thus hindering the easy leaching of 
the salt particles when washed with water. Moreover, a skin like smooth, 
only minimally porous layer is formed on the cast surface of the scaffold, 
when the solvent of the polymer is removed. This layer can inhibit removal of 
salt and organic solvent. To overcome the above limitations, the authors 
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(Liao et al. 2002) mixed the salt particles in the solid state polymer and 
placed into a mould, introducing the solvent under negative pressure to flow 
through the voids of the mixture. Particulate leaching technique has also 
been seen to be modified in various reported studies. For example, waxy 
hydrocarbons (Shastri et al. 2000) or gelatin/ paraffin microspheres (Chen 
and Ma 2004;Draghi et al. 2005) have been used as porogens. After 
compacting the particulate hydrocarbon porogen with a viscous polymer 
solution in a Teflon mold, the mixture is subjected to extraction in 
hydrocarbon solvent, like pentane or hexane, that is a nonsolvent for the 
polymer but miscible with the polymer solvent. Sugar (Hou, Grijpma, & 
Feijen 2003;McGlohorn et al. 2004) and paraffin microspheres (Draghi et al. 
2005) are other types of porogens used in some studies. 
  
3.4.2 Electrospinning 
 
Electrospun fibres have a greater specific surface area and a high porosity, 
hence has a better suitability for their application in fabrication of scaffolds. 
Electrospinning is capable of producing nano-scale fibres. Nano-scale fibres 
mimic the fibrous architecture of type 1 collagen, a component of 
extracellular matrix, and hence nanotechnology has gained widespread 
recognition in the field of biomaterials aiming for tissue engineering. Nano-
scale fibres are believed to result in a higher cell adhesion due to the high 
surface-to-volume ratio provided by them.  
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3.4.3 Compression Molding 
 
This is a technique where solid salt and polymer particles are mixed and 
then subjected to a compression in a mold at a high temperature (just above 
the melting or glass transition point of the polymer) and high pressure. The 
resultant composite is then removed from the mold after cooling to room 
temperature. Usually the composite is molded into cylindrical form, and then 
the cylinder is cut into discs of desired thickness before leaching in water. 
This technique is more likely to have a precise control of scaffold thickness 
and surface uniformity, as compared to the conventional solvent casting/ 
particulate leaching technique (Liao et al. 2002). However, there can be a 
thermal degradation of the polymer when subjected to high temperatures, 
and can be concerning (Mikos and Temenoff 2002). 
   
3.4.4 Gas Foaming 
 
Most of the techniques utilized to fabricate porous scaffolds typically use 
organic solvents. The residual organic solvent in the scaffold can be harmful 
to the seeded cells or growth factors. To overcome the above hazards, 
Mooney et al (Mooney et al. 1996a) developed an alternative technique 
called gas foaming which employs high pressure carbon dioxide saturating 
the solid polymer discs at room temperature for around 72 hours. The 
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solubility of the gas in the polymer is then rapidly decreased by reducing the 
gas pressure to atmospheric levels. This creates a thermodynamic instability 
for the CO2 dissolved in the polymer discs and results in the nucleation and 
growth of gas cells within the polymer matrix (Agrawal and Ray 2001). This 
technique has an advantage of obtaining porosity without using organic 
solvents. In a liquid polymer solution, gas bubbles can also be introduced by 
blowing an inert gas or using chemical blowing agents which liberate gas 
bubbles when heated. Gas foaming has been combined with particulate 
leaching when ammonium bicarbonate was used as salt. Literature shows 
that the mechanical properties were higher in scaffolds formed using gas 
foaming combined with solvent casting/particulate leaching when compared 
to those formed by standard solvent casting/particulate leaching process 
(Nam, Yoon, & Park 2000).  
 
3.4.5 Fibre meshes with fibre bonding 
 
As one of the earliest techniques to form constructs in tissue engineering, 
woven or knitted polymeric fibres have been widely accepted as useful 
scaffolds due to their property of large surface area for cell attachment and 
rapid diffusion of nutrients for cell survival and growth. Their structural 
instability in vivo was addressed by fibre bonding techniques (Mikos et al. 
1993) where the authors removed PLLA from PGA-PLLA copolymer by 
selective dissolution leaving PGA fibres physically joined at their cross points. 
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This fabrication technique results in foams with porosities as high as 81% 
and pore diameters of up to 500 microns (Mikos et al. 1993). 
 
3.4.6 Freeze Drying 
 
Emulsion freeze drying (Whang et al. 1995) is a technique where an 
emulsion is created by homogenization of a polymer solvent solution and 
water, rapidly cooling the emulsion to lock in liquid-state structure, and 
removing the solvent and water by freeze drying. Although large pore sizes 
of more than 200 µm were seen in the resultant samples, the median pore 
size ranged from 15 to 35 µm. Scaffolds had good pore interconnectivity and 
porosity greater than 90%. However the precise control of processing 
parameters is crucial to obtain the desired pore morphology, such as, 
volume fraction of the dispersed phase (water), polymer weight%, and 
polymer molecular weight. The use of organic solvents still remains a 
hindering factor to incorporate protein based growth factors during 
processing. Freeze drying combined with particulate leaching, as shown in a 
study using sugar template (Hou, Grijpma, & Feijen 2003) may result in an 
architecture consisting of relatively large interconnected pores due to the 
leached template, and smaller pores resulting from freeze drying process. 
 
3.4.7 Phase separation 
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Phase separation involves dissolving a polymer in a suitable solvent, placing 
it in a mould, and then cooling the mould rapidly until the solvent is frozen. 
The solvent is removed by freeze-drying, leaving behind the polymer as a 
foam with pore sizes of l-20 µm in diameter (Akki et al. 1999). 
 
3.4.8 Solid Free-Form fabrication (SFF)/ Rapid Prototyping (RP) 
 
Complex scaffold architecture designs may be created either using image-
based design approaches, or using approaches based on computer-aided 
design (Hollister 2005;Leong et al. 2003). The image based approach 
heavily employs computed tomography (CT) or magnetic resonance imaging 
(MRI), which design the scaffold exterior. However, designs can not be built 
readily using conventional techniques. Hence, scaffold architectures must be 
built using layer-by-layer manufacturing process known as Solid Freeform 
Fabrication (SFF) or Direct Writing or Rapid Prototyping. This technique 
usually incorporates the use of computer controlled four-axis machine with a 
multiple-dispenser head, or in other words a Rapid Prototyping Robot 
Dispensing (RPBOD) system, as called in one of the papers (Geng et al. 
2005).  Concentrated HA inks with tailored viscoelastic properties were 
developed to enable the construction of complex 3-D architectures 
comprised of self-supporting cylindrical rods in a layer-by-layer patterning 
sequence (Michna et al. 2005). Viscoelasticity of the polymeric ink is the 
most significant parameter in such 3D printing in order to allow the 
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construction of complex 3-D architectures comprised of self-supporting 
cylindrical rods in a layer-by-layer patterning sequence. 
 
SFF techniques can be based on laser, such as, Stereo- Lithography 
Apparatus (SLA) and Selective Laser Sintering (SLS), or can be based on 
print technology, such as, 3D printing (Hutmacher et al. 2004). Other forms 
of SFF include assembly technology-based systems such as Shape 
Deposition Manufacturing (SDM), or extrusion technology-based systems 
such as Fused Deposition Modelling (FDM), 3D plotting, Multiphase Jet 
Solidification (MJS) and Precise Extrusion Manufacturing (PEM). SLA uses 
UV laser that polymerises the liquid polymer material, which is then repeated 
in order to build up the design model, layer by layer (Hutmacher, Sittinger, & 
Risbud 2004). SLS uses a CO2 laser beam to sinter thin layers of powdered 
polymeric materials, forming solid 3D objects. 3D printing (Giordano et al. 
1996) uses an inkjet print head to deposit the binder solution to the selected 
regions of the layer of powder (polymer) bed. After the 2D layer is printed, a 
fresh layer of powder is laid down.  Such steps are repeated a selected 
number of times to produce successive layers of selected regions of bonded 
powder material so as to form the desired component. The unbonded 
powder material is then removed. In some cases the component may be 
further processed as, for example, by heating it to further strengthen the 
bonding thereof. SDM involves the fabrication of a layered scaffold in a 
customized geometry by processing the clinical imaging data and translating 
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it to the desired scaffold layer by a computer-numerically-controlled cutting 
machine. FDM employs the concept of melt extrusion of heated biomaterial 
through a small nozzle in order to obtain a layer of scaffold containing 
parallel material roads (Leong, Cheah, & Chua 2003). Changing the laydown 
pattern while adjusting the space between material roads, can provide the 
desired pore morphology with good interconnectivity (honeycomb pattern). 
The 2D structure thus obtained can be deposited onto the consecutive layers 
by changing the direction to obtain a 3D design. 
 
3.5 Surface modification of scaffolds 
    
Most of the biodegradable synthetic polymers (like PGA and PLA) are 
hydrophobic and may require modifications on their surface for better cell 
attachment. This can be achieved by surface coating, chemical coating, 
plasma treatment, or modifying the fabrication of scaffold itself (Wang, Cui, & 
Bei 2005c). Incorporation of a signal peptide into the biomaterial (scaffold) 
has attempted to mimic the extracellular matrix, modulate cell adhesion, and 
induce cell migration (Shieh & Vacanti 2005). A rough than a smooth fibre 
surface is favourable for cell attachment. Nanopatterning of biomaterial 
surfaces has been used as surface modification strategy to enhance protein 
activities, cellular functions and tissue responses. Coating the surface with 
extracellular matrix (ECM) proteins such as fibronectin, vitronectin, and 
collagen, provides an adhesive interface between the polymer scaffold 
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surface and cells that resemble the native cellular milieu. It is one of the 
simplest surface modification methods. The cell-binding domain of 
fibronectin, vetronectin and collagen contains the tripeptide RGD (Arg-Gly-
Asp) (Wang, Cui, & Bei 2005c). Stem cells from adipose tissue are found to 
attach better to scaffolds coated with peptide sequences derived from ECM 
laminin (Santiago et al. 2006).  
 
Examples of other coating methods include: chitosan nanoscaffolds modified 
with a sugar unit (Phongying et al. 2006), electrostatic coating of hyaluronic 
acid and chitosan onto polymeric scaffolds making them protein resistant 
(Croll et al. 2006;Mao et al. 2003), and coating of IGF 1 (insulin like growth 
factor) to collagen scaffolds showing increased osteoblast proliferation 
(Schleicher et al. 2005).  
 
In one of studies investigating tissue engineering of oesophagus, a 
biodegradable and flexible poly(L-lactide-co-caprolactone) (PLLC) copolymer 
was surface modified using aminolysis by 1,6-hexanediamine to introduce 
free amino groups. Using these amino groups as bridges, fibronectin and 
collagen were subsequently bonded with glutaraldehyde as a coupling agent. 
Protein-bonded surface presented to be more hydrophilic and homogeneous. 
In vitro long-term (12d) culture of porcine esophageal cells proved that 
fibronectin- and collagen-modified PLLC surface could more effectively 
support the growth of smooth muscle cells and epithelial cells (Schleicher et 
al. 2005;Zhu et al. 2006). 
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Self assembling peptide hydrogel scaffolds have been shown in many 
studies to effectively promote cell-material and cell-cell reactions enabling 
significant improvements in generating bone (Bokhari et al. 2005), cartilage 
(Kisiday et al. 2002), cardiovascular (Narmoneva et al. 2005) and neural 
tissues (Ellis-Behnke et al. 2006). These are basically amphiphilic peptides 
that have alternating repeating units of positively-charged lysine or arginine 
and negatively-charged aspartate and glutamate residues. These peptides 
contain 50% charged residues and are characterized by their periodic 
repeats of alternating ionic hydrophilic and hydrophobic amino acids; thus, 
the interaction between the distinct polar and non-polar surfaces facilitates 
self-assembly of the material into a nanofiber hydrogel scaffold which can 
coat surfaces or encapsulate cells as a 3-D weak gel (Holmes et al. 
2000;Kisiday et al. 2002;Zhang 2002). 
 
 In the field of small intestinal tissue engineering, most studies have used 
synthetic polymers, commonly PGA (Gardner-Thorpe et al. 2003;Grikscheit 
et al. 2004;Kim et al. 1999a;Kim et al. 1999b;Ramsanahie et al. 
2003;Tavakkolizadeh et al. 2003), and some have used SIS (Chen & 
Badylak 2001;Demirbilek et al. 2003;Wang, Watanabe, & Toki 2003) or 
collagen sponge (Hori et al. 2001). In majority of studies using PGA, the 
polymer was coated with 0.1-1 % collagen type I. As shown in one of the 
studies, a significant improvement was seen in cell engraftment, and larger 
cysts were formed when collagen was coated (92.9% v 63.6%) (Choi et al. 
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1998). SIS due to its richness in collagen has obviously an advantage over 
polymers to be used as a scaffold as far as cell attachment is concerned. All 
studies investigating small intestinal tissue engineering have used in vivo 
implantation of cell-polymer constructs. How intestinal epithelial units can be 
expanded ex vivo prior to their implantation is not clear and not published so 
far. All studies incorporating the use of intestinal epithelial units as the cell 
source have used only PGA polymers with or without PLLA. It is also not 
clear whether use of other synthetic polymers or natural polymers in a similar 
setup would have resulted in different results. Regulation of epithelial cell 
proliferation, migration and differentiation under physiological conditions is 
poorly understood. A better understanding of how the intestinal epithelial 
cells interact with their underlying basement membrane is required. A likely 
mechanism of this interaction as suggested by Beaulieu J F is through 
integrins, a specific subset of cell surface binding proteins (Beaulieu 1992). 
The epithelial basement membrane (BM) of the human intestine contains all 
major components specific to most BMs such as type IV collagens, laminins, 
and proteoglycans. However, a direct cause-to-effect relationships between 
particular integrins and specific cell functions, and the signalling molecules 
specifically involved need to be ascertained (Beaulieu 1992).  
 
 3.6 Discussion 
 
An ideal scaffold should be highly porous, and biocompatible with a 
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controlled degradation rate; should have an appropriate surface for cell 
adhesion, proliferation, and differentiation; and should maintain mechanical 
properties.  
 
Although macroporous scaffolds are generally accepted as ideal for soft 
tissue engineering, the size of the pore can depend on the size of the cell 
seeded. Interconnected pores larger than the cell size are generally required 
for infiltration of the cells into scaffold. Whereas on one hand pore sizes of 
greater than 50 µm facilitate better nutrient and cell transport, on the other 
hand micropores in sizes less than 20 µm are responsible for a greater 
surface area for protein adsorption, better ionic solubility in the 
microenvironment and cell attachment. In literature it has also been shown 
that a combination of macro- and micro-pores have resulted in better drug 
delivery, strength and stiffness particularly in bone tissue engineering, as 
compared to non-microporous scaffolds (Hing et al. 2005;Woodard et al. 
2007). Pore size requirements differ in different applications, for example, 
the minimum pore size required to regenerate mineralized bone is generally 
considered to be around 100 µm (Hulbert et al. 1970;Karageorgiou & Kaplan 
2005); and for soft tissue engineering like small intestine the pore size most 
widely used has been in the range of 250 µm (Kaihara et al. 1999;Kim et al. 
1999c), mainly because of the large size of intestinal epithelial organoid units 
used as the cell source. 
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Our laboratory has already demonstrated the advantages and the successful 
applications of silica nanocomposite based polyurethanes in producing 
vascular tissue engineered grafts, such as improved cell adhesion 
characteristics using a silicon pendant nanocage (Kannan et al. 2006b). PCL 
in our experience has been less expensive, and easily dissolvable in 
commonly available organic solvents unlike PGA which is very hard in 
consistency and requires highly fluorinated solvents such as 
hexafluoroisopropanol. Our nanocomposite maintains mechanical stability 
due to nanocages while simultaneously allowing controlled degradation.  
 
In this chapter, we analysed different methods available to fabricate 
scaffolds, and also attempted to address pitfalls associated with them. 
Although Solid Freeform Fabrication (SFF) techniques offer the most reliable 
methods to design and fabricate complex 2D and 3D scaffolds with more or 
less precise reproducibility and control over pore morphology, they are not 
free from shortfalls. Due to shrinkage after processing, Stereo Lithography 
Apparatus (SLA) has a compromised resolution, and due to scattering of 
laser beam, there can be deformation of the smaller scaffolds (Hutmacher, 
Sittinger, & Risbud 2004). Selective Laser Sintering (SLS) also has a 
potential problem of material shrinkage when sheet like structure is desired, 
and porosity may not be obtained as desired. 3D printing is vastly explored 
and in fact is one of the most promising methods to produce accurate design 
of scaffolds; however the resolution of the 3D printer is limited by the nozzle 
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size and the inkjet print head movement. Polymers may need special 
processing techniques to make them in powder form prior to 3D printing, and 
the particle size of the powder governs the layer thickness (Giordano et al. 
1996;Hutmacher et al. 2004). Fusion Deposition Modeling (FDM) is one of 
the most investigated SFF methods, and has been quite successful in 
producing scaffolds (Hutmacher et al. 2001;Zein et al. 2002) using 
biopolymers as well as ceramics, but the technique is not without limitations. 
High processing temperatures and hence limited material range, inconsistent 
pore opening in different directions, and requirement of support structures for 
irregular shapes are some of the limitations (Leong, Cheah, & Chua 2003). 
The combination of toxic organic solvents and extreme temperatures, for 
example, in fiber bonding technique, presents difficulties if cells or bioactive 
molecules, such as growth factors, are to be included in the scaffold during 
processing. Another issue can be the choice of solvent, as suggested by a 
study (Sander et al. 2004), which suggests that solvent choice can create 
small but significant differences in scaffold properties, and that the rate of 
evaporation is more important in affecting scaffold microstructure. For 
example, specimens fabricated in methylene chloride were the stiffest, 
followed by acetone and then chloroform.    
 
Particulate leaching/ solvent casting is a simple and inexpensive method to 
fabricate 2D scaffold sheets of desired thickness. Different porosities and 
pore sizes can be obtained. The sheets can be rolled in a tubular structure if 
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needed to simulate structures like vessels or intestine. One of the significant 
disadvantages of solvent casting/ particulate leaching, and other techniques 
including phase separation, fiber bonding and gas foaming, is the need of 
organic solvent which can be cytotoxic, and hence there is a need to remove 
the solvent which can take long processing time. The newly developed 
techniques of rapid prototyping/ solid freeform fabrication can certainly be 
the answer to the above problems as they are usually porogen free and 
solvent free. They can be used to result in highly reproducible architecture, 
there is a precise control over pore-morphology and mechanical properties, 
and the technique can include bioactive components like cells, growth 
factors and drugs during fabrication. However, these techniques are 
expensive, sophisticated equipment is required, and relatively less porosity 
is obtained as compared to the conventional techniques. Methods commonly 
employed in characterization of scaffolds include SEM and mercury intrusion 
porosimetry (MIP). SEM is a simple and relatively inexpensive tool to show 
surface topography of a 3D scaffold in form of pore size, pore density, pore 
structure, and pore interconnectivity to an extent. However, only 2D analysis 
and destruction of the scaffold sample are the limitations associated with it. 
Despite these limitations, SEM remains the most widely accepted 
characterization method of choice. MIP offers a better idea of the porosity of 
the scaffold sample as a whole. Relatively newer tools such as micro-CT has 
been quite successful to demonstrate pore morphology, mainly pore-
interconnectivity, but quantification of pore-interconnectivity has not been 
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simple, as it requires use of complicated computer software to analyse data. 
 
Following our review of literature, we experimented our laboratory made 
nanocomposite POSS-PCL for its fabrication characteristics using two main 
techniques: solvent casting/particulate leaching and electrohydrodynamic 
atomisation. These experiments are described in chapters 5 and 6 
respectively. 
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Chapter 4: Materials and Methods 
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4.1 Introduction 
 
 
Experiments were carried out exploring biodegradable nanocomposite 
developed in our laboratory to form scaffolds for small intestinal tissue 
engineering as described in the following three chapters. First experimental 
chapter includes synthesis of nanocomposite, its characterisation, and 
fabricating porous scaffolds using solvent casting/particulate leaching 
technique. These porous scaffolds were then characterised for their 
mechanical strength, porosity, and chemical structure. In the second 
experimental chapter, electrohydrodynamic atomisation technique was 
employed to attempt fabricating porous scaffolds. In the third experimental 
chapter, these scaffolds were tested in vitro for intestinal epithelial cell 
growth.  
 
Our laboratory has developed a biodegradable nanocomposite by 
incorporating the biostable polyhedral oligomeric silsesquixane (POSS) 
nanocages into a poly(caprolactone/carbonate)urethane urea. They are 
approximately 6 nm in size. The molecular structure of nanosized silicon-
oxygen cages (POSS) is shown in figure 4.1. 
 
 100 
 
 
Figure 4.1: Molecular structure of trans-cyclohexane diol isobutyl-POSS. 
 
 
Our nanocomposite is polyurethane which has a soft segment composed of 
polycaprolactone (80%) and polycarbonate (20%), and hard segment 
composed of urea. The polymer is approximately 22% by wt hard segment. 
Eighty percentage of polycaprolactone diol (mwt) was considered an 
appropriate initial formula for use as a tissue engineering scaffold for small 
intestine or cartilage. Such a scaffold would be required to maintain its 
structural integrity for at least 4–6 months (Raghunath et al. 2008). PCL is 
relatively slow to degrade as compared to PGA or PLLA, which is an added 
advantage in tissue engineering of soft structure like small intestine where a 
slow degradation is required over a period of few months rather than weeks. 
It is proposed that caprolactone will provide controlled degradation whilst the 
POSS nanocages will contribute to the mechanical strength required for a 
tissue engineering scaffold for soft tissue such as small intestine. 
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4.2 Synthesis of POSS-PCL nanocomposite 
 
 
Dry polyol blend (80% by wt polycaprolactone diol and 20% by wt 
polycarbonate diol) and trans-cyclohexanediolisobutyl-polyhedral oligomeric 
silsesquioxane (POSS) were placed in a 250ml reaction flask equipped with 
mechanical stirrer and gas inlet. The mixture was heated to 130°C to 
dissolve the POSS cage into the polyol and then cooled. Subsequently, flake 
MDI was added to the polyol blend and then reacted, under nitrogen, at 70°C 
- 80°C to form a pre-polymer. Dry DMAC was added slowly to the pre-
polymer to form a solution, which was cooled to 40°C. Chain extension of the 
pre-polymer was carried out by the drop wise addition of a mixture of 
ethylenediamine and diethylamine in 80g of dry DMAC. After completion of 
the chain extension 1-butanol in DMAC was added to the polymer solution to 
form a 2% polyhedral oligomeric silsesquioxane – polycaprolactone (POSS-
PCL) solution. The resultant polymer solution was 20 wt % in DMAC. All 
chemicals and reagents were purchased from Aldrich Ltd., Gillingham, UK.  
 
 
4.3 Characterisation of polymer solutions 
 
 
 
20 wt% polymer in DMAC were used in all experiments. The surface tension, 
viscosity and electrical conductivity, properties which affect 
electrohydrodynamic behaviour, were measured. Surface tension was 
measured using a Kruss Tensiometer K9 (Du Novy’s ring method). Viscosity 
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was estimated using a Visco-Easy rotational viscometer. Electrical 
conductivity was assessed using a HACH SensION Tm 156 probe. All 
measurements were performed at the ambient temperature and all 
instruments were calibrated before use. 
 
4.4 Preparation of scaffolds using particulate leaching/ 
solvent casting 
 
We intended to develop scaffolds with two pore sizes: 150-250 microns 
(macroporus) and <150 microns (microporous). Dried NaCl was sieved in the 
desired pore size range using stainless steel sieves (Fisher Scientific, U.K). 
10 wt. % POSS-PCL in DMAC was used in all experiments. Two different 
salt concentrations - 40 and 80 weight percentages in polymer were used for 
both macroporous and microporous salt sizes. Both salt sizes were mixed in 
one of the samples to obtain a mixed pore sized sample. Control sample 
was prepared without any salt in it. Salt was mixed in the polymer solution 
using a hand held homogeniser (Ultra-Turrax T25 from IKA labortechnik, 
Staufen, Germany) and then poured over stainless steel plates to spread. 
The mixture was left in the oven at 50° C for 20 hours. The sheets of 
polymer were peeled off the plates and kept in de-ionised water for 48 hours 
with a regular change of water at 4 hourly intervals. After 48 hours the 
polymer sheets were air dried and specimen from the samples were studied 
for their physical and chemical properties. 
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4.5 Extrusion – Coagulation combined with Solvent Casting/ 
Particulate Leaching 
 
Extrusion-coagulation or extrusion-phase inversion is a process where 
exchange between solvent and non-solvent takes place resulting in 
formation of pores. In this process a casting solution consisting of polymer 
and solvent is immersed into a nonsolvent coagulation bath (Young and 
Chen 1995). Interchange of solvent and nonsolvent due to diffusion causes 
the casting solution to go through a phase transition by which the membrane 
is formed. Pore size and its distribution, can be controlled for each specific 
application depending on the choice of the polymer, solvent, non-solvent and 
preparation parameters. Liquid-liquid phase separation in miscible polymer 
solution can be caused by variation in temperature and/or composition of the 
mixture. When a homogeneous solution becomes thermodynamically 
unstable, the solution can decrease its free energy from mixing by dividing 
into two liquid phases of different composition, i.e., a nucleus of the polymer-
poor phase that forms the nascent pore and a polymer-rich phase that 
surrounds the pore. Hence, a nascent pore comprises the polymer-poor 
phase surrounded by the polymer- rich phase.  
 
We used the salt mixed nanocomposite as the polymer having DMAC as 
solvent; and de-ionised water as the non-solvent. We used 80 wt % NaCl in 
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the size range of 150-250 microns in sample 1, and NaHCO3 salt particles in 
the range of <50 microns in sample 2. Sample 3 was extruded without any 
salt in it serving as a non-porous control. A mechanical arm was positioned 
such that it held a 5 mm diameter stainless steel cylindrical mandrel within 
the exit aperture of a stainless steel polymer chamber. This latter structure 
comprised a circular 5 mm entry aperture superiorly; a luer-lock syringe 
compatible polymer introduction channel laterally; a 6 mm circular exit 
aperture inferiorly; and a PTFE sliding cover for the exit aperture (Sarkar et 
al. 2009a). The mandrel cross-section was aligned perfectly concentric with 
respect to the exit aperture. With the mandrel’s base level with the exit 
aperture, the PTFE sliding cover was closed before 3.5 ml of nanocomposite 
that was injected slowly into the polymer chamber. For this step it was 
imperative that the syringe contained no air bubbles. A vertical column of 
coagulant solution was placed directly below the sliding cover leaving a 5 
mm gap between the two. The cover was opened and the mandrel driven 
vertically into the coagulant at 10 mm/s immediately afterwards. The column 
was undisturbed for 20 min then placed in a separate chamber having de-
ionised water for 48 hours. Thereafter, the mandrel was removed from the 
coagulant, dried and the scaffold tube removed from the mandrel. Scanning 
electron microscopy was used to visualise the details of the wall cross-
section and pores.  
 
4.6  Characterisation of Scaffolds 
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We used scanning electron microscopy as our main tool to aid 
characterisation of the porous scaffolds, particularly to look into the pore 
morphology like pore size, pore-pore interconnectivity, and pore shape. To 
measure porosity in percentage, we used the formulae given below, where 
density of the polymer was first calculated and then of the scaffold. Further 
pore morphology and interconnectivity was studied using micro CT as 
described in section 4.6.3.  
 
4.6.1 Porosity of Scaffolds 
 
The porosity of the scaffolds was calculated by using simple formulae: 
 
pd
dP −= 1
 
Where P is the porosity of the scaffold sample, d is the density of the 
scaffolds, and dp is the density of the nonporous polymer. Density of the 
scaffold d was calculated from: 
 
v
md =  
 
Where, m is the mass and v is the volume of the scaffold. The volume, v was 
calculated using thickness and diameter of the scaffolds obtained when 
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casted over circular steel plates.  
 
4.6.2 Scanning Electron Microscopy (SEM) 
 
SEM provides a high resolution, highly detailed views of a surface of scaffold, 
however it is limited to the 2D measurements. Moreover, although the pore-
interconnectivity can be seen in the 2D views, its quantification is not easy to 
perform unless the number and size of pores inside the pores, is measured 
(Murphy et al. 2002). Pore interconnectivity has been better quantified using 
micro-Computed Tomography (micro CT) (Moore et al. 2004). The samples 
were attached to aluminium stubs with double sided sticky tabs and then 
coated with gold using an SC500 (EMScope) sputter coater before being 
examined and photographed using a Philips 501 scanning electron 
microscope at 15KV.  
 
4.6.3 Micro-CT 
 
Scanning Electron Microscopy and Mercury Intrusion Porosimetry have a 
disadvantage of sample destruction. Micro-CT has an advantage of non-
destructiveness and 3D image analysis including structural measurements 
(Filmon et al. 2002;Moore et al. 2004). X-ray microtomography is a non-
destructive technique to provide internal and microstructural details of an 
object. There is no need for extensive sample preparation, and three-
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dimensional information can be obtained at high spatial resolution. Polymer 
scaffolds with high void fractions are analysed for the volume of their void 
space remaining accessible to outside air at increasing minimum connection 
sizes. The accessible volume is the pore volume that is accessible, from the 
outside, to an object of selected diameter. The scaffold microstructure can 
then be assessed quantitatively with the use of a computer programme of 
image display and analysis. The accessible void fraction can be calculated 
as the number of air voxels maintaining connections with the outside air as a 
percentage of the total air voxels. Micro-CT data can be reconstructed to 
obtain 3D structure of cross sectional images taken at a mere 8 µm distance 
throughout the thickness of the scaffold.  
 
In this study, although the pore morphology was mainly studied by SEM and 
the porosity was calculated by using formula mentioned above, however for 
one sample (sample 1), porosity and pore size of the scaffolds were also 
investigated by X-ray microtomography, in order to validate the results. The 
porous scaffold sample was examined using a SkyScan-1072 high resolution 
desktop X-ray microtomography system (Skyscan, Belgium). The X-ray 
radiographs were collected at 20kv/120µA with 0.5mm Al filter, a 8 µm pixel 
size, 0.23° angle step (0° to 180° rotation) and 3 frame averages per 
acquired radiograph. A cone-beam accusation was selected and cone-beam 
volumetric reconstruction (Feldkamp algorithm) was employed for image 
reconstruction. During the image reconstruction process, the beam 
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hardening correction parameter was set to 20 ~ 30%, depending upon the 
individual sample. Each original reconstructed image contained 1024x1024 
pixels. The porosity and pore size were calculated and analysed using CTAn 
software as the mean value of 100 sections studied. 
 
4.6.4 Mechanical Properties 
 
Mechanical tests were performed in uniaxial tension on a ZWICK BDO-
FB.5TS tester (Ulm, Germany) unit at room temperature. Specimens in the 
form of flat dumbbells with a 40-mm-long working part were loaded at a 
constant tension rate of 100 mm/min. Thickness of samples was measured 
using a digital electronic outside micrometer (UKAS Calibration, Corby, U.K) 
at three places of the dumbbell and averaged. Stress-strain relationships 
were obtained for the samples and graphs were plotted. 
 
4.6.5. Fourier transform infrared spectroscopy (FTIR) 
 
Infrared spectra of a porous and nonporous scaffold were recorded on a 
Perkin-Elmer 1750 FTIR spectrometer equipped with a triglycine sulphate 
detector. Spectral data were acquired from a 10 µl volume gas tight CaF2 cell 
(path length 6 µm) and the temperature of recorded spectra was 25°C. A 
sample shuttle was employed to permit the sample to be signal-averaged 
with the background. For each sample, 200 scans were signal averaged at a 
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resolution of 4 cm-1.  
 
4.7 Electrohydrodynamic print-patterning for development of 
scaffolds  
Regular 
polymeric drop
Cone and polymeric 
micro-thread produced 
and patterned by action 
of computer input
Voltage OnVoltage Off 
Flow Flow
600 µm
Polymeric threads 
patterned onto ethanolData entry into 
computer. 
Direct link up 
with printer.
1mm approx 
0. 5-2 mm approx 
Glass slide 
as substrate
Needle
 
Figure 4.2: Schematic illustration of the electrohydrodynamic process 
 
Electrohydrodynamic jetting is a process where a liquid medium forms a jet 
and breaks into droplets as it is released at a controlled flow rate through a 
needle while being exposed to an electric field caused by the existence of a 
potential difference between the needle and a ground electrode (Rayleigh 
1878;Taylor 1964;Zeleny 1917) (figure 4.2). This method was first adapted 
for the processing of advanced materials in 1997 (Teng et al. 1997). 
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POSS-PCL solution was printed onto standard microscope glass slides 
(75mm x 25 mm) using a needle of internal diameter 750µm and an applied 
voltage in the range of 8.0 to 10.0 kV, which was further optimised 
depending on the type of polymer used and the presence or absence of 
ethanol on the glass slide as a substrate. The distance between the needle 
exit and the glass slide was also carefully adjusted from ~500µm to ~2mm 
depending upon the above mentioned two variables. The flat-bed printing 
speed was kept constant at 10m/s. Using Motion Planner software, the 
computer was programmed to generate a 10x10 mm square sheet in the X-Y 
plane, with the distance between the grid lines (scaffold window size) set at 
250µm. Assuming that all the droplets of polymer may not deposit over their 
predecessors, and also as the diameter of the material forming the structure 
would occupy some of the pore space, we increased the window size from 
250 to 500 µm, in order to eventually achieve ~250 µm. The schematic 
representation of electrohydrodynamic printing is shown in figure 4.3 
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Figure 4.3: Schematic representation of electrohydrodynamic printing. 
 
The program was set up so that the pattern was repeated in the Z direction 
up to 20 and then 50 times, with an intention of obtaining ~500µm to 1 mm 
thick scaffold, assuming the printing generates material strands of diameter 
15-50 µm. The polymer solution wetted and spread on the glass slides even 
at a very low infusion rate of 1µlitre/hour, and hence only a drop of polymer 
was mechanically pushed through the needle onto the glass slide. However, 
when over-printing in the Z-direction was explored, the sample dried after 
about 5-6 repetitions as enough polymer did not emerge through the needle 
tip. In any case, the resultant sample could not be peeled off the glass slide 
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as it was not sufficiently thick. In another set of experiments, the same 
printing technique was used to collect polymers on a glass slide having a 
layer of ethanol. The latter samples could be peeled off the glass slides. 
Firstly, printed scaffolds were studied under low magnification (5x) with a 
Nikon Eclipse optical microscope. Subsequently, samples were also 
investigated using a JEOL JSM-6301F scanning electron microscopy 
operating at an acceleration voltage of 5-10 kV. Samples were sputter 
coated with gold prior to electron microscopy. The equipment used consisted 
of a stainless steel needle with an internal orifice diameter of 750 µm. It was 
held in epoxy resin and a point-like electrode was held directly below the 
axis of the needle. The needle was connected to a high voltage power 
supply (Glassman Europe Ltd., Tadley, UK), which was capable of applying 
up to 30 kV. The inlet of the needle was connected to a Harvard PHD 4400 
programmable syringe pump (HARVARD Apparatus Ltd., Edenbridge, UK) 
using a silicone rubber tube, allowing the flow rate of liquid to the needle exit 
set to ≥ 1µl/hour. This equipment was coupled together with servomotor 
drive in the x and y directions and stepper-motor drive in the z direction. The 
three-axis system was controlled using a programmable motion controller, 
which communicates directly with a personal computer. A perspex table was 
mounted firmly on the y-axis cradle. The top of the table accommodates a 
frame for the substrate. The frame was fitted to the base of the table using 
four polyethylene terephthalate stilts. Three pieces of software were used for 
generating the final geometry. Initially TurboCad was used and subsequently 
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CompuCAM translates the computer aided design file into the Motion 
Planner software. Eventually, this software is downloaded to the three-axis 
controller using x, y, and z coordinates. 
 
4.8 Cell Work 
 
 
The following flow chart (figure 4.4) summarises the sequence of in vitro 
experiments to grow rats’ intestinal epithelial cells (IEC-6) on polymer 
scaffolds. 
 
  
 
Figure 4.4: An overview of cell culture experiments. TCP = Tissue Culture Plastic; 
LDH = Lactate Dehydrogenase; AB = Alamar Blue; SEM = Scanning Electron 
Microscopy 
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4.8.1 Optimising seeding density for IEC-6 cells on tissue culture plastic 
without scaffolds 
 
As a preliminary step an optimum cell density was obtained by culturing rat’s 
intestinal epithelial cells (IEC 6 cell line, ECACC, Salisbury, U.K.) on tissue 
culture plastic without using scaffolds. Cells were counted and diluted to 
obtain 2, 1, 0.5, 0.125, 0.0625, 0.03125 x 105 cells per ml of culture medium 
{DMEM supplemented with 0.1 IU/ml Insulin and 5% Foetal Bovine Serum 
plus penicillin at 100U/ml and streptomycin at 10µg/ml (all Invitrogen, 
Paisley, U.K.)}. Six wells of a 24 well plate (BD Falcon, Oxford, U.K.) were 
seeded for each concentration above and one left as blank. They were 
seeded overnight. The next day (Day 1), medium was removed, washed with 
PBS and 1 ml 10% Alamar Blue (AB) was added. AB was left for four hours 
and then removed. Duplicate samples of 100µl were read on fluorescent 
plate reader. AB assay was repeated on Day 4, Day 7, and Day 14.  
 
4.8.2 Optimising seeding time for IEC-6 cells on tissue culture plastic without 
scaffolds 
 
Two cell concentrations 1 x 106 cells /ml and 0.25 x 106 cells /ml, were 
seeded (n=6 each) on tissue culture plastic without scaffolds in 24 well 
plates. Alamar Blue assays were performed at time points 2, 3, 4, 6 and 24 
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hours (n=6 each) on Day 1 and Day 3 with a blank row. At each time point 
non-adherent cells were removed, washed with 1 ml PBS and 1 ml fresh 
medium was added. 
 
4.8.3 Scaffold preparation for cell seeding 
 
Scaffold sheets were cast by solvent casting and salt leaching in order to 
obtain desired porosity, as described earlier, and thoroughly washed in 
distilled water. Circular discs of 15mm diameter from each sample were then 
cut using a metal die. Discs were then autoclaved to sterilise them. 
 
4.8.4 Trial seeding of scaffold samples with lower density of 0.25 x 105 cells 
 
Scaffold samples and controls were seeded overnight with 0.25 x 105 cells in 
24 well plates. On Day 1 (next day), 500 µl AB was added for 4 hours to 
each well after washing with PBS. Single 100 µl samples were read on 
fluorescent plate reader.  AB assay was repeated on Day 3 and Day 7. 
 
4.8.5 Trial seeding of scaffold samples with higher density of 0.25 x 106 cells 
 
Two samples each of scaffolds were cut and used for cell culture in 24 well 
plates. 0.25 x 106 cells per ml concentration was used for trial seeding of the 
grafts. 1 ml was added to each well with controls. Cells were allowed to seed 
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overnight on the scaffolds. Alamar blue assays were done on samples above 
and the samples were read in duplicates (day 2). Alamar Blue assays were 
repeated on Day 8. 
 
4.8.6 Higher cell density seeding of scaffolds washed with stringent washing 
regime 
 
In this set of experiments, a more stringent regime of washing the scaffold 
samples was used before seeding them with cells. Scaffolds were rinsed in 
deionised water for 72 hours on a shaker with changes of water every 4 
hours. A higher cell density of 0.25 x 106 was used to seed scaffold samples 
(n=6 each) plus blanks and positive controls. All experiments were carried 
out in 24 well plates. Samples were left overnight to seed. Plastic inserts 
were used to avoid floating of the scaffold sample in the medium. Tissue 
culture plastic wells with no scaffold in were seeded with an identical amount 
of cells as a positive control. Wells with scaffold but no cells were employed 
as a negative control. Cells were allowed to attach for 24 hours after which 
the medium containing unattached cells was removed for lactate 
dehydrogenase (LDH) analysis to assess initial cell damage. The seeded 
scaffold discs were then transferred to a fresh 24 well plate (to avoid the 
possibility of measuring cells seeded onto the initial well bottom during the 
seeding process) and cell metabolism assessed using an Alamar blueTM 
assay. AB was added for 4 hours and single 100 µl samples were read on 
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the fluorescent plate reader. 1 ml fresh medium was replaced in each well. 
On Day 3 and Day 6, same was repeated except no samples were collected 
for LDH. On Day 6, one set of samples (6th sample from each scaffold) was 
saved for SEM (scanning electron microscopy). On Day 9 LDH assay was 
repeated and samples of scaffold were dismembrinated and weighed. 
Alamar Blue assays were repeated on Day 10, 14, and 21. One set of 
scaffold samples was collected for SEM analysis. 
 
4.8.7 Assessment of Initial Cell Damage by LDH analysis 
 
LDH was measured using a CytoTox 96® Non-Radioactive Cytotoxicity 
assay kit (Promega, Southampton, U.K.). LDH is a stable cytosolic enzyme 
released upon cell lysis into the cell culture medium. The amount of LDH 
released is measured using a 30-minute coupled enzymatic assay based on 
the conversion of a tetrazolium salt INT (2-p-iodophenyl-3-p-nitrophenyl-5 –
phenyl tetrazolium chloride) into a red formazin product, with the amount of 
colour formed being proportional to the number of lysed cells. 50µl cell 
culture medium from each sample was transferred to a 96 well plate (Helena 
Biosciences, Sunderland, U.K). 50µl Substrate Mix (1 vial substrate plus 
12mls assay buffer) was added to each well and the plate covered in foil to 
prevent light access. Samples were then incubated at room temperature for 
30 minutes after which the reaction was stopped by the addition of 50µl stop 
solution (1M acetic acid). Absorbance was then read at 450nm using a 
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Multiscan MS UV visible spectrophotometer (Labsystems, Ashford, U.K.). 
 
4.8.8 Assessment of Cell Growth and Metabolism by Alamar blueTM assay 
 
Alamar blueTM (Serotec, Kidlington, U.K.) is a commercially available assay 
which aims to measure quantitatively cell proliferation, cytotoxicity and 
viability. This is achieved by incorporating resazurin and resarfurin as 
colorimetric oxidation reduction indicators. These indicators respond to 
chemical reduction resulting from cell metabolism by changing colour. This 
colour change may be measured by monitoring fluorescence (excitation at 
530nm, emission at 620nm). The advantages of this assay are that it is 
soluble in media, stable in solution, minimally toxic to cells and produces 
changes that are easily monitored. 
 
Alamar blue was added to cell culture medium at a concentration of 10% 
(v/v). At each time point polymer samples were washed with 1 ml PBS and 
transferred to a fresh 24 well plate to prevent the possibility of measuring 
cells growing on the bottom of the plate. 0.5 ml of the Alamar blue/cell 
culture medium mixture was then added to each sample and the positive 
control wells. 0.5 ml of the mixture was placed into each of the negative 
control samples. After 4 hours a 100µl sample of the mixture was removed 
and the absorbance at fluorescence (excitation at 530nm, emission at 
620nm) measured in a 96-well plate (Helena Biosciences, Sunderland, U.K.) 
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using a Fluoroscan Ascent FL spectrophotometer (Thermo Labsystems, 
Ashford, U.K).  
 
 4.8.9 Statistical analysis 
 
 
Statistical analysis of the results was performed using GraphPad Prism 
version 5 software. The groups were analysed for statistical significance by 
one way ANOVA tests. P<0.05 was considered statistically significant. 
Tukey’s multiple comparision test was used to compare individual set of 
readings. 
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Chapter 5 
 
 
 
Development and Characterisation of highly porous 
scaffolds by Solvent Casting and Particulate-
Leaching  
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In this chapter we report the successful use of solvent casting and 
particulate leaching technique in fabrication of scaffolds from POSS-PCL in 
desired porosity considered suitable for tissue engineering of small intestine. 
These scaffolds were cast in linear sheets. The scaffolds were then 
characterised for their pore morphology, pore interconnectivity and 
mechanical strength.   
 
5.1 Experimental details 
 
Scaffolds were made porous by using sodium chloride particles in two size 
ranges: 150-250 microns (macroporus) and <150 microns (microporous). 
Dried NaCl was sieved in the desired pore size range using stainless steel 
sieves. 10 wt. % POSS-PCL in DMAC was used in all experiments. Two 
different salt concentrations - 40 and 80 weight percentages in polymer were 
used for both macroporous and microporous salt sizes (table 5.1). Both salt 
sizes were mixed in one of the samples to obtain a mixed pore sized sample. 
Control sample was prepared without any salt in it. As shown in figure 5.1, 
circular discs of 1.5 cm diameter were cut using a metal die and these 
specimens from the samples were studied for their physical and chemical 
properties. 
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Figure 5.1: Porous scaffold developed using solvent casting/ particulate leaching. 
Circular discs of 1.5 cm diameter were cut using a metal die for cell culture purposes. 
 
Table 5.1 Scaffold samples with different salt concentrations and size 
 
Sample# Concentration of NaCl in polymer (wt 
%) 
NaCl particle size 
(µm) 
1 80 150-250 
2 40 150-250 
3 80 <100 
4 40 <100 
5 (control) 0 (No salt) - 
6 80 <100 + 150-250 
 
 
 
 
 
1.5 cm 
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5.2 Characterisation of the scaffolds 
 
We used scanning electron microscopy as our main tool to aid 
characterisation of the porous scaffolds, particularly to look into the pore 
morphology like pore size, pore-pore interconnectivity, and pore shape. To 
measure porosity in percentage, we used the formulae described in 
materials and methods. Scaffolds were further characterised for pore 
morphology and pore interconnectivity using Micro CT, and for their 
mechanical properties using stress-strain graphs. FTIR was used to provide 
further evidence of POSS surface enrichment, and to assess any deviation 
in the basic structure of the nanocomposite after solvent casting/ particulate 
leaching was used. 
 
5.3 Results 
 
5.3.1 Properties of polymer  
 
Table 5.2 shows the physical properties of nanocomposite POSS-PCL used 
in this study. The methods used to measure these properties have been 
described in section 4.3. Viscosity of POSS-PCL nanocomposite is 
significantly high making the nanocomposite a viscous solution to fabricate 
into scaffolds.  
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Table 5.2 Physical properties of the POSS-PCL polymer and organic solvent. Values 
are mean ± SD (n=3). 
 
Sample Surface Tension 
(mNm-1) 
Electrical 
Conductivity  
(10-4 Sm-1 ) 
Viscosity  
( mPa s) 
DMAC 36 ± 0.4 0.2 ± 0.01 2.2 ± 0.12 
POSS-PCL 48 ± 0.3 1.7 ± 0.10  9720 ± 120 
 
We also tested the viscosity of non-biodegradable counterpart of our 
nanocomposite (POSS-PCU), which was 2494 ± 106. The nanocomposites 
have DMAC within and possible interactions of soft segment with DMAC give 
the biodegradable nanocomposite a much higher viscosity. In order to 
facilitate homogenous mixing of salt in solvent casting/particulate leaching 
process, the nanocomposite was diluted with DMAC to make 10 wt % 
solution.   
 
5.3.2 Porosity of scaffolds 
 
The table below (table 5.3) shows varying porosity obtained when salt was 
used in different concentrations and different particle sizes. The porosity 
obtained was calculated using simple formulae described in materials and 
methods, section 4.5.1. Composite mixture of salt and POSS-PCL was 
weighed before casting and dried porous sheets after peeling off the 
stainless plates were also weighed before being submerged in de-ionised 
water for particulate leaching.   
 125 
 
Table 5.3: Porosity of POSS-PCL scaffolds using different salt concentrations and 
salt sizes. Sample 5 (control) is the sample with no salt. Porosity values are mean ± 
SD (n=3) 
 
 
Sample Concentration of NaCl (wt%) 
in polymer 
NaCl particle size 
(µm) 
Porosity obtained** 
(%) 
 
1 
 
80 
 
150-250 
 
83.9±0.5 
 
2 
 
40 
 
150-250 
 
59.5±0.9 
 
3 
 
80 
 
<100 
 
74.6±0.4 
 
4 
 
40 
 
<100 
 
61.9±0.3 
 
5 (control) 
 
- 
 
- 
 
 5.4±6.0 
 
** Porosity, 
pd
dP −= 1
 and 
v
md =  
To estimate the density and porosity of scaffolds after particulate leaching, 
the diameter and height of each scaffold were measured to calculate the 
volume of each scaffold. The results show that the porosities obtained (%) 
are in the desired range and close to the weight percentage of salt used as a 
porogen. 
 
5.3.3 Scanning Electron Microscopy (SEM) 
 
Porous morphology of scaffolds was examined by SEM taken from the 
surface of linear 2D sheets, as well as from their cross section as shown 
below. Pore interconnectivity was seen in SEM micrographs and confirmed 
by micro CT pictures which are described in section 5.3.5.  
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Figure 5.2: SEM of scaffold sample 1 (80% porous). Magnification x10. Scale bar is 2 
mm. Inset is the photograph of 1.5 cm diameter disc cut from scaffold sample 1. 
 
 
Figure 5.3: Surface SEM of scaffold sample 1 (80 % porosity). Magnification x20. 
Scale bar is 500 µm. 
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Figure 5.4: Cross sectional SEM of scaffold sample 1 (80 % porosity). Magnification 
x20. Scale bar is 500 µm. 
   
 
Figure 5.5: SEM of scaffold sample 1 (80 % porosity). Magnification x80. Surface 
micrograph. Scale bar is 250 µm. Pore within a pore can be seen (P). Small pores (p) 
are likely due to undesired small salt particles after sieving.  
 
P 
p 
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Figure 5.2 and figure 5.3 show a surface SEM picture where a 
homogenous distribution of pores can be seen. Pores are in the size range 
of the salt particles used, i.e. 150 – 250 microns and pore interconnectivity 
can be seen as well. Figure 5.4 is a cross sectional micrograph of the same 
scaffold sample 1 with 80 % salt concentration to achieve porosity in the 
range of 80%. Figure 5.5 is the magnified surface micrograph of the same 
scaffold where pore within a pore can be seen. The small pores seen are 
likely to be due to undesired small salt particles and some air bubbles 
trapped while mixing salt in the polymer using a homogenizer. Pore 
intercoonectivity was further characterized using micro CT as described in 
section 5.3.5.   
 
Samples 2 and 4 showed porosity in the range of 40 % as desired (figure 
5.6); however sample 2 has a larger pore size than sample 4, as expected.  
 
Figure 5.6: Scaffold samples 2 and 4 in the range of 40 % porosities but sample 2 has 
a larger pore size (150 – 250 µm) as apposed to sample 4 which has smaller pore size 
(<100 µm). Scale bar is 500µm. Magnification is x 20 in both micrographs.  
 
Sample 2 Sample 4 
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Sample 3 was intended to have a small pore size (< 100 microns), which can 
be seen in figure 5.7. This sample of scaffold was mixed with 80 % salt of < 
100 micron salt particles. As can be seen in the micrographs, pore sizes are 
in the desired range. The porosity was confirmed to be in the range of 74.6% 
as shown in table 5.3.  
 
  
 
Fig 5.7: SEM of sample 3 (80 % salt concentration with salt particle size < 100 
microns). Magnification x 20 and x 160. Scale bar is 125 microns as shown. Pore size 
can be seen < 100 microns as desired.  
 
The non-porous sheet of scaffold (sample 5) where no salt was used served 
as a control. As we know, coagulation of a polymer into a non-solvent results 
in pore formation, however, no pores can be seen in SEM micrograph of 
sample 5, figure 5.8, suggesting all the solvent (DMAC) evaporated as 
expected, resulting in no coagulation process when the dried sheet was 
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leached in de-ionised water.  
 
  
Figure 5.8: Surface SEM micrograph of scaffold (sample 5). No salt was used for 
casting. No pores can be seen. Magnification x 80. 
 
5.3.4 Extrusion-coagulation combined with salt leaching 
 
Porous scaffolds in form of 5 mm tubes were developed by the method of 
extrusion –coagulation as described in section 4.5. This method is also 
called liquid-liquid phase inversion. In this method the tubes of scaffolds 
obtained were kept in deionised water for 48 hours not only for coagulation 
of the liquid polymer, but also to facilitate controlled porosity by leaching the 
salt particles with known size range and quantity.  SEM pictures (figure 5.9) 
of the samples showed mixed pore sizes, due to a combined effect of 
particulate leaching resulting in large pores (150-250 microns); and small 
pore (<50 microns) formation due to phase inversion.  
P5 
P6 
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Figure 5.9: SEM of tubular scaffold (sample 1) developed using combined extrusion-
coagulation and particulate (NaCl 150-250µm) leaching. Mixed pore size is observed. 
Scale bar is 125µm. 
 
 
Sample 2 was obtained by using NaHCO3 in place of NaCl. NaHCO3 is much 
finer salt as compared to NaCl and the salt particles are in the range of < 50 
µm. SEM (figure 5.10) of the tubular scaffold graft obtained using combined 
phase-inversion and particulate (NaHCO3) leaching reveals pores in the 
range of <50  µm and porosity in the range of 80%.  
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Figure 5.10: SEM of tubular scaffold (sample 2) developed using combined extrusion-
coagulation and particulate (NaHCO3 <50 µm) leaching. NaHCO3 leads to formation of 
small pore size as opposed to NaCl. Scale bar is 125 µm. 
 
 
5.3.5  Micro CT 
 
The results of Micro CT (Figure 5.11) confirmed the porosity calculated by 
using simple formulae. As a mean value from 100 sections of the sample 1 
was found to be 80% ± 2%, and the pore size varied from 140-250 µm, as 
expected from the polymer-salt ratios. Good pore interconnectivity was seen 
in the sample studied. 
X 160 
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Figure 5.11: Micro-CT images of the cast scaffold of sample 1 rolled as a tubular graft 
(a) sagittal section (b) cross section. Pore interconnectivity can be seen in both 
sections. The outer thick white line is an artefact from the tape used to secure the 
sample while processing for micro-CT. Pores are seen black whereas polymer and 
very little salt left is seen white. 
 
5.3.6  Stress-Strain values 
a 
b 
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Stress–strain patterns of scaffold samples are shown in figure 5.12. Porous 
scaffolds (samples 1, 2, 3, 4 and 6) are significantly less stiff as compared 
with the non-porous scaffold (sample 5); P<0.05. As expected, the porous 
scaffolds were less strong than the non-porous scaffold; however, among 
the porous scaffolds with different porosities and pore sizes, there was no 
significant difference observed. Pore size has no significant influence on 
stress strain patterns. Table 5.4 shows stress-strain measurements of 
POSS-PCL macroporous and microporous scaffolds.  
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Figure 5.12: Graph represents stress-strain of POSS-PCL scaffolds samples 1-6. 
Sample 5 is the non-porous (control). The data are mean values (n=3) prepared with 
salt concentrations of 40 and 80 wt %. 
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Table 5.4: Stress-Strain values of scaffolds 
 
 
 
Keys: a0-thickness, b0-width, L0-length experimented, S0-cross sectional area, σFmax-maximum stress, σR- shear stress at break, εR – 
percent elongation, σ50 – shear stress at 50% elongation. 
 
 
 
 
S
a
m
p
l
e
#
 
a0 
mm 
B0 
mm 
L0 
mm 
S0 
mm2 
σFmax 
N/mm2 
σR 
N/mm2 
εR % σ50 
N/mm2 
σ100 
N/mm2 
σ200 
N/mm2 
σ300 
N/mm2 
σ500 
N/mm2 
1 0.64 4 22.50 2.58 1.93 1.84 261.1 0.62 0.95 1.79 3.04 - 
2 0.41 4 21.42 1.54 3.15 3.08 334.7 0.82 1.27 2.06 2.86 - 
3 0.46 4 21.11 1.86 2.69 2.53 270.9 0.90 1.39 2.23 - - 
4 0.28 4 20.99 1.12 4.43 4.41 367.4 0.86 1.39 2.45 3.61 - 
5 0.16 4 20.20 0.64 46.21 41.92 942.5 4.01 5.50 8.44 12.09 20.12 
6 0.54 4 21.25 2.19 3.57 3.52 398.3 0.75 1.15 1.91 2.76 - 
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5.3.7 Fourier transform infrared spectroscopy (FTIR) 
 
FTIR was performed as a characterization tool for scaffolds prepared by 
solvent casting/particulate leaching technique. The aim was to confirm the 
preservation of the basic structure of scaffold despite attaining porosity by 
adding salt particles. We studied FTIR for a porous (sample 1) and a 
nonporous (sample 5) and plotted the graph as shown in figure 5.13.  
 
  
Figure 5.13: FTIR of porous sample (sample1) and non-porous sample (control – 
sample 5), essentially showing preservation of basic structure of scaffold after 
particulate leaching. 
 
The results showed that the basic structure of scaffold remained preserved 
after particulate leaching. The carbonyl segment of ester/carbonate (--CO—
O--), the urethane carbonyl groups (--NHCOO--) and the C—O--C bonds of 
the CO—O--C segments have characteristic peaks at wavelengths 1725, 
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1640, and 1240–1250 cm-1 respectively and constitutes the soft segment. 
The urethane amides of the hard segment have characteristic peaks at 1525 
and 1223 cm-1. The Si-O bonds of the POSS nanocages revealed 
characteristic peaks at a wavelength of 1100 cm-1. PCL exhibits 
characteristic C-O and C-C bond stretching at a wavelength of 1157 cm-1 
and carbonyl stretching at 1728 cm-1.  
 
5.4 Discussion 
 
Although macroporous scaffolds are generally accepted as ideal for soft 
tissue engineering, the size of the pore can depend on the size of the cell 
seeded. Interconnected pores larger than the cell size are generally required 
for infiltration of the cells into scaffold. Whereas on one hand pore sizes of 
greater than 50 µm facilitate better nutrient and cell transport, on the other 
hand micropores in sizes less than 20 µm are responsible for a greater 
surface area for protein adsorption, better ionic solubility in the 
microenvironment and cell attachment (Woodard et al. 2007). In literature it 
has also been shown that a combination of macro- and micro-pores have 
resulted in better drug delivery, strength and stiffness particularly in bone 
tissue engineering, as compared to non-microporous scaffolds (Hing et al. 
2005). Pore size requirements differ in different applications, for example, 
the minimum pore size required to regenerate mineralized bone is generally 
considered to be around 100 µm (Hulbert et al. 1970;Karageorgiou & Kaplan 
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2005); and for soft tissue engineering like small intestine the pore size most 
widely used has been in the range of 250 µm (Kaihara et al. 1999;Kim et al. 
1999c), mainly because of the large size of intestinal epithelial organoid units 
used as the cell source. 
 
Our laboratory has already demonstrated the advantages and the successful 
applications of silica nanocomposite based polyurethanes in producing 
vascular tissue engineered grafts, such as improved cell adhesion 
characteristics using a silicon pendant nanocage (Kannan et al. 2006b). In 
this study we developed and characterised similar, although biodegradable, 
nanocomposite POSS-PCL scaffolds for intended use in small intestinal 
tissue engineering. Another aim of this study was to suggest suitability of 
alternative biodegradable polymers like POSS-PCL for soft tissue 
engineering, as opposed to the widely accepted sole use of PGA/PLLA 
copolymers in small intestinal tissue engineering. PCL in our experience has 
been less expensive, and easily dissolvable in commonly available organic 
solvents unlike PGA which is very hard in consistency and requires highly 
fluorinated solvents such as hexafluoroisopropanol. Our nanocomposite 
maintains mechanical stability due to nanocages while simultaneously 
allowing controlled degradation. In this study, we used mainly two pore sizes 
– 150-250 µm and < 100 µm. Apart from the pore size, we also used two 
different porosities, one in the range of 80% and the other in the range of 
40%. Solvent casting and salt leaching resulted in the production of scaffolds 
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with pore size and porosity in the desired range. The pores were 
interconnected as can be seen on SEM and micro CT. Solvent casting unlike 
extrusion-coagulation (phase inversion) offers an added advantage of 
controlled pore size and porosity. Our scaffold samples when tested for 
stress strain relationships show that the strength of scaffold reduces with 
increasing porosity. 
 
We employed simple and inexpensive method of particulate leaching/ 
solvent casting to fabricate 2D scaffolds of desired thickness. We developed 
sheets of scaffolds in different porosities and different pore sizes. Our aim 
was to test our house made biodegradable nanocomposite (POSS-PCL) for 
its fabrication properties, and then to subject the scaffold to physical and 
chemical tests in order to characterise its suitability as a scaffold to grow 
intestinal cells first in vitro, and then in vivo. With the technique of solvent 
casting/particulate leaching described above, we obtained 2-3 mm thick two 
dimensional porous sheets of polymer which could be rolled in a tubular 
structure if needed in future. The surface of the sheets towards the stainless 
plates on which they were cast was smooth and relatively non porous as 
compared to the porous surface exposed to air. This is a well known finding 
by other researchers who have used the similar method of solvent casting 
and particulate leaching (Wake et al. 1996; Liao et al. 2002). It is believed 
that the solvent as well as the salt (particulate) particles evaporate and 
disperse towards a gas interface due to buoyancy, resulting in a porous 
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exposed surface and a relatively smooth inner surface in contact with the 
metal plate on which the composite is cast.  This difference in surface 
morphology can be overcome by making thicker sheets and then essentially 
bisecting the base (smooth skin) to give porosity at both surfaces. This can 
be achieved by using compression moulding technique where the salt-
polymer composite can be compression moulded in cylindrical form, and 
then the cylinder is cut indo discs of desired thickness before leaching. 
However, high temperatures can degrade the polymer in this process 
(Thomson et al. 1998). One of the significant disadvantages of solvent 
casting/ particulate leaching, and other techniques including phase 
separation, fiber bonding and gas foaming, is the need of organic solvent 
which can be cytotoxic, and hence there is a need to remove the solvent 
which can take long processing time. The newly developed techniques of 
rapid prototyping/ solid freeform fabrication can certainly be the answer to 
the above problems as they are usually porogen free and solvent free 
(Hutmacher et al. 2004; Hollister 2005). They can be used to result in highly 
reproducible architecture, there is a precise control over pore-morphology 
and mechanical properties, and the technique can include bioactive 
components like cells, growth factors and drugs during fabrication. However, 
these techniques are expensive, sophisticated equipment is required, and 
relatively less porosity is obtained as compared to the conventional 
techniques. Moreover, for our intention to develop scaffolds for tissue 
engineering of small intestine, highly sophisticated structure was not 
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required. We aimed to develop a highly porous and macroporous scaffold of 
our nanocomposite which has a large surface area and thickness of 
approximately 2 mm in order to allow cells to grow and survive, in vitro. The 
simple linear sheets of scaffolds can be rolled out in tubular structures in 
future for vivo studies, if necessary, to simulate a tubular small intestine. The 
main objective for engineering small intestinal remains to increase the 
absorptive surface of gut, which can be achieved by forming scaffold in any 
shape, whether tubular like an intestine, or, spherical like a cyst. With solvent 
casting and salt leaching, a highly porous scaffold was obtained with desired 
thickness in the range of 2-3mm, and porosity in the range of 80%. Methods 
commonly employed in characterization of scaffolds include SEM and 
mercury intrusion porosimetry (MIP) (Liao et al. 2002;Mikos et al. 1994; Nam 
et al. 2000;Murphy et al. 2002). SEM is a simple and relatively inexpensive 
tool to show surface topography of a 3D scaffold in form of pore size, pore 
density, pore structure, and pore interconnectivity to an extent. However, 
only 2D analysis and destruction of the scaffold sample are the limitations 
associated with it. Despite these limitations, SEM remains the most widely 
accepted characterization method of choice. Relatively newer tool, such as, 
micro-CT has been quite successful to demonstrate pore morphology, 
mainly pore-interconnectivity, but quantification of pore-interconnectivity has 
not been simple, as it requires use of complicated computer software to 
analyse data.     
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The scaffold samples in different pore sizes and porosity were analysed with 
scanning electron microscopy for pore morphology, and the scaffolds were 
also tested for their mechanical strength by a tensometer. Pore morphology 
was further confirmed by micro CT which clearly demonstrated the pore 
interconnectivity, and testified our porosity calculated from simple formulae. 
The porosity achieved was in accordance to the amount of salt used. FTIR 
was performed to identify the amount of residual salt in the scaffold samples 
and also to know the deviation from the original structure of the polymer after 
the processing was done in form of solvent casting/ particulate leaching. 
FTIR of porous (sample1) and non-porous sample (control-sample 5) 
showed preservation of basic structure of scaffolds after particulate leaching. 
We have used samples of scaffolds with two different porosities of 80% and 
40%, and two pore sizes of <100 µm and 150-250µm, for our in vitro 
experiments to test cell growth and cell proliferation. The in vitro experiments 
are described in chapter 7. 
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Chapter 6 
 
Electrohydrodynamic atomisation – novel use for 
print patterning of biopolymer scaffolds 
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6.1 Introduction 
 
Electrohydrodynamic jetting is a process where a liquid medium forms a jet 
and breaks into droplets as it is released at a controlled flow rate through a 
needle while being exposed to an electric field caused by the existence of a 
potential difference between the needle and a ground electrode (Rayleigh 
1878;Taylor 1964;Zeleny 1917) and this method was first adapted for the 
processing of advanced materials in 1997 (Teng et al. 1997). 
Electrohydrodynamic jetting occurs in many modes (Cloupeau and 
Prunetfoch 1990;Jaworek and Krupa 1999), e.g., microdripping, spindle, 
cone-jet, multi-jet, and the mode is mainly determined by the properties of 
the liquid, the flow rate, and applied voltage. The cone-jet mode is where the 
formation of a cone takes place at the exit of the needle; a jet emerges from 
its apex, breaking down into droplets further away from the apex (Hartman et 
al. 1999). The stable cone-jet mode is most desirable, as it can generate a 
near monodispersion of droplets (Edirisinghe and Jayasinghe 
2004;GananCalvo et al. 1997;Hartman et al. 2000). Both microsuspensions 
and nanosuspensions have been subjected to this process successfully in 
our earlier studies and print patterned in 2D (Jayasinghe et al. 2002;Wang et 
al. 2005a) and, more recently, with high resolution patterning device in 3D 
(Wang et al. 2005b). Electrospinning is another related process and is 
accompanied by a cone of liquid at the exit of the needle where a jet evolves 
and elongates into one or more filaments, which solidify on or soon after 
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deposition (Doshi and Reneker 1995;Shin et al. 2001). This process is an 
attractive way of preparing fibres and fibre-mats from advanced materials 
(Sigmund et al. 2006;Zhang and Edirisinghe 2006). Recently it was shown 
that electrically forced microthreading is a related but distinctly different 
phenomenon, which could be exploited in materials processing (Zhang et al. 
2006b). We achieved this with biopolymers in this experimental work and to 
the best of our knowledge; this was the first time electrohydrodynamic 
printing was used to prepare scaffolds for tissue engineering. One 
advantage of electrohydrodynamic printing over ink-jet printing is that much 
larger sized nozzles used (750 µm in this work) prevent needle-blockages 
allowing easier processing of the viscous polymer solutions to finer 
dimensions. Our direct writing electrohydrodynamic print-patterning 
procedure described in this chapter is attractive as with little modification, the 
structure of scaffold prepared can be tailored to the needs of many 
applications. 
 
6.2 Experimental Details 
 
Experimental details are described in section 4.7. POSS-PCL solution was 
subjected to the process of electrohydrodynamic atomisation and when 
aided with computer software, as described in section 4.7, resulted in 
printing fibres in a pre-designed pattern. This was printed onto standard 
microscope glass slides. 
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6.3 Results 
 
Details of the structural features of the polymers are described in section 4.1 
(Kannan et al. 2006a). The polymer contains hard and soft segments and 
show three regions, POSS segments, which are surrounded by urethane 
and these two constitute the hard segment, and carbonate soft segments, 
which also incorporate POSS. In the biodegradable polymer the soft 
segments are predominantly composed of polycaprolactone, which contains 
ester groups. 
 
Table 6.1: Properties of the nanocomposite polymer, DMAC and ethanol 
Sample Surface Tension/mNm-1 
 
Electrical  
Conductivity/ 10-4  Sm-1  
Viscosity/mP
a.s 
Ethanol 23 1.5 1.3 
DMAC 36 0.2 2.2 
POSS-
PCL 
48 1.7 9720 
 
Due to soft segment differences and also the possibly different interactions 
with DMAC gives the biodegradable polymer a much higher viscosity and a 
lower electrical conductivity (table 6.1). However, the latter quantity is 
comparable with ethanol and much higher than the electrical conductivity of 
silicone oils we investigated recently and therefore classical 
electrohydrodynamic jetting is anticipated (Zhang et al. 2006a). However, the 
influence of higher viscosity seems to favour stable electrically forced 
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microthreading (Zhang, Jayasinghe, & Edirisinghe 2006b) rather than simple 
jetting and droplet generation (figure 6.1).    
  
Figure 6.1: Stable electrically forced microthreading of the biopolymer 
 
6.3.1 Scaffold characteristics 
 
Initial print-patterning results showed discontinuities in the scaffolds 
prepared from the polymer (figure 6.2). This problem was overcome with the 
careful adjustment of the distance between the needle tip and the glass slide 
to approximately 500µm (figure 6.3); however, the printed structures could 
not be peeled-off from the glass substrate. When polymer was printed onto 
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ethanol kept on the glass slide, instant precipitation of the polymer deposits 
occurred. Printing on to ethanol was much smoother with stable jetting. A 
few discontinuities are seen in the scaffolds prepared and these are caused 
by unstable jetting probably caused by variations of flow rate, the importance 
of flow rate is discussed below. Microscopy of the scaffolds prepared 
showed that a wavy and coil-like pattern prevailed when polymer was 
deposited on to ethanol (figure 6.4). Moreover, single layer prints with or 
without ethanol on the glass slides were fragile and did not sustain their 
structure when peeled off the substrate. When overprinting was performed 
five times in the presence of ethanol, the resultant scaffold could be peeled-
off the glass slide and sustained its structure (figure 6.5).  
 
   
Figure 6.2: Optical micrographs showing discontinuous printing  
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Figure 6.3: Optical micrographs showing continuous printing 
 
 
   
 
Figure 6.4: Scanning electron micrograph of a single layer of scaffold printed from 
polymer, showing coiling.  
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Figure 6.5: Scanning electron micrograph of a scaffold printed from polymer and 
subsequently peeled off the glass substrate. 
 
6.4 Discussion 
 
This work was carried out in relation to our research on tissue engineering 
small intestines and in most reports of other workers (Choi & Vacanti 
1997;Duxbury et al. 2004;Kaihara et al. 1999;Kim et al. 1999a;Kim et al. 
1999c;Vacanti et al. 1988) where the scaffold used has been made of tubes 
fabricated from non-woven sheets of polyglycolic acid fibres with or without 
poly (L-lactic acid) with a fibre diameter of 5-15 µm, mesh thickness of 1-2 
mm with a porosity of 95% due to a mesh window size of 250 µm. The use of 
a macroporous scaffold (pore diameter >100 µm) in tissue engineering of 
soft structures like the small intestine is justified to facilitate important 
functions of better cell attachment, mass transport and waste disposal. 
Therefore, in this experimental work, our aim was to prepare 10x10 mm 
square sheets with a pore size in the range of 250 µm using the 
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nanocomposite POSS-PCL. 
 
In this study we printed two grid patterns – a smaller grid (window size 
250µm) and a larger grid (window size 500 µm). As seen in scanning 
electron micrographs, the samples are macroporous with a reduction of 
window size by ~ 30-100µm than the designed levels corresponding to the 
size of the polymer strand forming the window. One of the factors affecting 
smaller than expected window size could be the possible shrinkage of the 
scaffold due to drying after printing.  
 
The coiled appearance of the polymers printed on ethanol may be attributed 
to the instant precipitation of the polymer solution in ethanol. Selecting a 
liquid medium where precipitation of the polymer is more controlled may be 
important. Polymer deposits printed directly on the glass slide without 
ethanol are seen to be straight or wavy but not coiled. Desired uniform 
polymeric threads were obtained at an applied voltage of 9.5 kV when 
POSS-PCL was printed onto glass slides without ethanol. The distance 
between the exit of the needle and the glass slide was ~500µm. However 
when ethanol was used as a layer of substrate over glass slide, this distance 
had to be increased to ~1.5mm in order to avoid spreading of the polymer 
threads away from the main printed line. Also, with ethanol present, the 
optimum voltage for smooth continuous was found to be slightly higher, in 
the range of 9.5-10.0 kV. This change could be attributed to an increased 
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electric force required for the polymeric threads to precipitate through 
ethanol onto the glass slide, and for a higher voltage required to atomise the 
more viscous biodegradable polymer.  
 
One of the limitations of our experiments was the inability to obtain 0.5-1 mm 
thick scaffolds because over-printing could not be carried out more than five 
times in the z direction. This was directly related to the flow rate of the 
polymer from the needle. The best scaffolds were obtained when a drop of 
polymer was manually pushed to the tip of the needle and atomised. This 
quantity was sufficient to over-print five times, after which the polymer at the 
tip of the needle solidified due to evaporation of solvent. More than the 
optimal amount of polymer solution required for atomisation was delivered 
even at a minimum infusion rate of 1 µl/hour of the pump used, making 
“blobs” of polymer deposit on the scaffolds. This limitation may be overcome 
by refining the flow rate using better and finer adjustable infusion in future.  
 
Due to the ability to pre-design the scaffold structure, window size can be 
tailored to the desired levels by altering the distance between the grid lines 
while writing the programme on the computer. This technique can also be 
exploited to design various shapes of the scaffolds as the medium subjected 
to electrohyrodynamic jetting can also be printed in the form of curvilinear 
and circular pattern in addition to straight lines.     
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6.5 Conclusions 
 
This was a successful attempt to print polymer solution into a pre-designed 
structure of a scaffold for tissue engineering using electrohydrodynamic 
technology. Prints on ethanol resulted in almost instantaneous precipitation 
of the polymer facilitating peeling off the scaffold from the substrate. 
Scanning electron microscopy of the peeled scaffolds revealed a 
macroporous structure with polymer strands of diameter 15-50 µm. The 
polymer strand diameter was found to be dependent on the distance 
between the needle exit and the substrate, the voltage applied and the 
viscosity of the polymer solution. Further studies are required to study the 
exact relationship of the former with the latter three variables. Further work is 
also required to attempt making thicker scaffolds, may be by controlling the 
flow rate more accurately. The window morphology and the physical 
properties of the scaffold need to be tested in further studies. An ideal 
polymer ink with optimal characteristics for printing by electrohydrodynamic 
flow remains a viable option.  
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Chapter 7 
 
 
 
In vitro small intestinal epithelial cell growth on a 
nanocomposite polycaprolactone scaffold 
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7.1 Introduction 
 
In chapter 5 we developed and characterised porous scaffolds aimed at 
tissue engineering of small intestine using solvent casting/ particulate 
leaching; and in chapter 6 we employed electrohydrodynamic printing to 
develop scaffolds in desired pore size. The scaffolds developed were 
characterised for their physical properties and pore morphology. In this 
chapter we further characterised them for their cell compatibility by culturing 
rats’ intestinal epithelial cells in vitro, before they can be tested in vivo in 
experimental animal models. We chose scaffolds developed using solvent 
casting/ particulate leaching for the studies. The reason was firstly an 
inability to obtain sufficiently thick scaffolds from the later technique, and 
secondly a requirement for large number of scaffolds to be tested which was 
achieved by the easy processability of solvent casting/ particulate leaching 
technique. Our aim was to test the cell viability and cell proliferation when 
grown on scaffolds as substrates of different porosities and different pore 
sizes. We also aimed at optimising the number of cells required to be 
seeded before a confluent cell growth could be achieved. 
 
7.2 Experimental Details 
 
In vitro studies were conducted using circular discs of POSS-PCL scaffolds 
on which rats’ intestinal epithelial cells were attempted to grow. The aim was 
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to test the scaffolds for cytocompatibility and cell proliferation. Firstly, cell 
culture was done on tissue culture plastic without scaffolds in order to get 
optimisation of cell density and cell seeding time. Cells were allowed to seed 
for 24 hours. Trial experiments of cell culture on POSS-PCL scaffolds with 
0.25 x 105 cells per ml was followed by increase in cell density to 0.25 x 106 
cells per ml. A more stringent washing of scaffolds prior to cell culture was 
done in the final experiments with higher cell density seeding. Cell adhesion 
was studied by Alamar Blue assays. Initial cell damage was studied by 
lactate dehydrogenase assay. Samples of seeded scaffolds were also 
analysed by scanning electron microscopy at day 7 and day 21.   
 
7.3 Results 
 
7.3.1 Optimising seeding density for IEC-6 cells on tissue culture plastic 
without scaffolds 
 
Rats’ intestinal epithelial cells (IEC-6) were grown on tissue culture plastic 
(n=3) in order to obtain an optimal seeding cell density. Cells were diluted to 
obtain concentrations ranging from 0.03125 to 2 x 105 cells per ml. Our aim 
was to seed the scaffold samples with minimum possible cell density, as 
higher cell densities are likely to inhibit cell growth after a certain time due to 
overcrowding and subsequent cell death, and can spuriously show high 
readings on Alamar blue assays.  
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Figure 7.1: Optimal cell density (column graph above and bar graph below). Alamar 
blue assay for growth on tissue culture plastic over a period of 2 weeks at different cell 
densities. Results are mean ± SEM (n=3).   
 
In figure 7.1 it can be seen that cell densities of 0.5 x 105 cells per ml and 
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higher attain confluence after 1 week, whereas 0.25 x 105 cells per ml and 
lower still significantly continue to grow till the 2 week period (p<0.05). There 
was a significant difference (p<0.05) between cell growth from 96 hours to 1 
week at a density of 0.25 x 105 cells per ml; as compared to growth at cell 
density of 0.5 x 105 cells per ml. The minimum cell density which resulted in 
significant cell proliferation over next two weeks was 0.25 x 105 cells per ml. 
Cell density below this concentration was not sufficient to proliferate. 
 
7.3.2 Optimising seeding time for IEC-6 cells on tissue culture plastic without 
scaffolds 
 
Prior to carrying out the cell seeding experiments on scaffold some 
preliminary work was done to examine cell adhesion and proliferation on 
tissue culture plastic. The cell adhesion study examined adhesion after 2, 3, 
4, 6 and 24 hours seeding time at two seeding densities (0.25 and 1 x 106 
cells per well) as shown in figure 7.2.  
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Figure 7.2: Optimal seeding time for cell adhesion. Alamar blue assay for adhesion on 
tissue culture plastic at different time points for optimising cell seeding time. Results are 
mean ± SEM (n=3). 
 
These studies indicated that all the cells were adherent after 4 hours 
seeding. Based on this a 24 hour seeding period was used in the scaffold 
experiments on the assumption that the maximum number of cells would 
have attached by this time point. For both cell densities, there was no 
significant difference after 4 hours (p>0.05).  
 
7.3.3 Trial seeding of scaffold samples with lower density of 0.25 x 105 cells 
 
Polymer scaffolds (P1-6) were seeded in 24 well plates with 0.25 x 105 for a 
period of one week. Alamar Blue assays were performed on day 1, 3, and 7 
(figure 7.3). No significant difference in cell growth was observed over one 
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week period (p>0.05).  
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Figure 7.3: Trial seeding of the grafts with 0.25 x 105 cells per ml. Results are mean ± 
SEM (n=6). P1-6 are polymer scaffold samples; D1, D3 and D7 are days after cell 
seeding.  
 
In the graph for trial seeding (figure 7.3), the red bars represent tissue 
culture plastic (TCP) on which significant cell growth occurs over one week 
period (p<0.01). TCP with cells but no scaffold served as a positive control. 
Growth on TCP indicates optimal growing conditions and technique. It is 
possible that the cell seeding density as suggested by trial growth on TCP is 
suboptimal when grown on the scaffold surface rather than TCP alone.  
 
7.3.4 Trial seeding of scaffold samples with higher density of 0.25 x 106 cells 
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After unsuccessful attempt at growing cells onto the scaffold with a cell 
density of 0.25 x 105 cells per ml, a higher cell density of 0.25 x 106 cells per 
ml was used in the study to examine cell growth over a period of 8 days. As 
can be seen in figure 7.4, cell growth occurred when Alamar Blue assays 
were done on day 2. However Alamar Blue assays when repeated at day 8, 
there was a significant drop (p>0.05) in the graph bars suggesting either cell 
death due to cytotoxic agents while growing, or cell death due to over 
crowding. It was believed that the residual salt used as particulate while 
developing cast sheets of porous scaffold could be cytotoxic. The other 
possible cytotoxic agent could be residual DMAC. The washing regime was 
initially to just rinse the scaffolds in de-ionised water. This was then made 
more stringent by rinsing the scaffolds for 72 hours on a shaker with 
changes of water every 4 hours.  
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Figure 7.4: Trial seeding of scaffolds with 0.25 x 106 cells per ml. Alamar Blue assays 
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were performed on day 2 and day 8 of cell seeding. Results are mean ± SEM (n=3)  
 
7.3.5 Higher cell density seeding of scaffolds washed with stringent washing 
regime 
 
After trial seeding of cells onto scaffolds, a higher cell density of 0.25 x 106 
cells per ml, rather than 0.25 x 105 cells per ml, was deemed optimal; and 
the washing regime of scaffolds was made more stringent with regular 
change of de-ionised water. The results obtained from the investigation of 
cell growth and metabolism of IEC cells seeded on the various polymer 
samples demonstrate that cell growth occurred over the course of the 21 day 
study (figure 7.5). When seeded on tissue culture plastic cells reached 
confluence by day 10 (TCP control). All polymer samples showed a 
reduction in cell metabolism compared to the positive control, p<0.01 (as 
anticipated, tissue culture plastic being optimal for cell growth). However cell 
growth occurred on each polymer sample over the whole 21 day period 
suggesting a slower growth rate compared to tissue culture plastic. There 
was no significant difference in growth (p>0.05) for different porosities and 
pore sizes over the time period investigated.  
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Figure 7.5: Alamar blue cell viability assay test on IEC seeded on POSS-PCL samples 
over 21 days. Data are mean ± SEM (n=6). P1-P6 are discs of polymer samples 1-6. 
TCP is tissue culture plate control. 
 
No further data was collected after 21 days growth as we believed that this 
was a reasonable period to demonstrate successful cell growth on the 
scaffolds and wished to collect samples for SEM analysis at this point. The 
cells grew at a reasonably steady rate over this time period and the SEM 
pictures demonstrate that they were approaching confluence at this point.  
 
7.3.6 Assessment of Initial Cell Damage by LDH analysis 
 
LDH release was examined to look at potential cell damage in the initial 
seeding period (figure 7.6). The differences in LDH levels are actually quite 
small compared to the levels from the tissue culture plastic seeded cells 
indicating that little initial cell damage has occurred. It is not possible to 
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calculate the number of cells represented by the LDH levels. 
Bl
an
k
Po
sit
ive
Sc
aff
old
s 
(P1
-
P6
)
0.0
0.1
0.2
0.3
0.4 (b)
LDH
A
bs
o
rb
an
ce
 
@
 
45
0n
m
(a)
Bl
an
k
Po
sit
ive P1
P1
 
bla
nk P3
P3
 
bla
nk P4
P4
 
bla
nk P6
P6
 
bla
nk P9
P9
 
bla
nk P1
0
P1
0 b
lan
k
0.20
0.25
0.30
0.35
0.40
Ab
so
rb
an
ce
 
@
45
0n
m
 
Figure 7.6: LDH assay test on IEC seeded on POSS-PCL samples for 24 hours. 
Absorbance was measured in arbitrary units at 450 nm wavelength. Data are mean ± 
SEM (n=3). P1 to P6 are the seeded discs of polymer samples 1-6. ‘Positive’ indicates 
sample with equal number of cells seeded on the tissue culture plate without the 
polymer discs, serving as a positive control. (a) individual readings (b) combined  
scaffolds’ readings. 
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When statistical analysis was carried out on the levels for the scaffold 
samples there was in fact no significant difference (p > 0.05) between the 
cell damage from positive and scaffold samples.  
 
 
7.3.7 Assessment of Cell Seeding by Scanning Electron Microscopy 
 
The results obtained from SEM examination of seeded polymer samples at 
Day 21 show cells present on all polymers examined and confirm the 
findings of the cell metabolism study (figure 7.7). 
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Figure 7.7: SEM of scaffolds (P1-P6) after 21 days of cell (IEC 6) seeding. Scale bar is 
250µm. Results show cells approaching confluence at day 21.  
 
Cells are seen in figure 7.7 to approach confluence at day 21. P1 – P6 are 
scaffolds with different pore sizes and porosities. P5 is the non porous 
scaffold. A confluent cell layer is formed in all the scaffolds on their surface 
P1 
P6 P5 
P2 
P3 P4 
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and cell in-growth is porous scaffolds is suggested as seen in figure 7.8. 
Figure 7.5 shows the alamar blue results for the different scaffolds over a 21 
day period. It demonstrates that cell growth did occur as there is a significant 
increase in alamar blue levels over the period examined. Cell in-growth is 
suggested by growth of cell layer within pores as seen in the figure 7.8.  
 
 
Figure 7.8: Cell layers are seen to encroach in pores from the surface suggesting cell 
in-growth.   
 
7.4 Discussion 
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Multipotent stem cells in intestinal layers are believed to regulate intestinal 
epithelial cell lineages; and can regenerate whole intestinal crypts (Brittan & 
Wright 2002). However their location and fate is not much identified due to 
lack of distinct cell markers. Attempts have been made to grow cells on 
polymeric scaffolds but with little success. They include seeding autologous 
mesenchymal cells onto collagen scaffold (Alison et al. 2000;Hori et al. 
2002); epidermal growth factor induction to grow pluripotent stem cells from 
peripheral blood to differentiate into epithelial cells  (Zhao, Glesne, & 
Huberman 2003) has not been much successful.  
 
Intestinal epithelial organoid units isolated from neonatal rats (Choi & 
Vacanti 1997) have been seeded onto PLGA copolymers with some success. 
Unit-polymer constructs when implanted in rats’ omentum have grown cysts 
with characteristics of intestinal tissue regeneration.  
 
However an ideal cell source for intestinal tissue engineering has not been 
identified yet. Perhaps stem cells which can be signalled to grow towards 
intestinal lineage may prove to be the solution to this complex problem.  
 
In this study, we used rat’s intestinal epithelial cell (IEC-6) to test our 
nanocomposite POSS-PCL for supporting cell growth and proliferation. IEC-
6 cells have an epithelioid morphology, grow as monolayers of closely 
opposed polygonal cells, and has a population doubling time of 19-22 hours 
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(Quaroni et al. 1979). These cells have features of undifferentiated small 
intestinal crypt cells. We tested cell vialbility and proliferation onto our 
scaffolds so that these scaffolds can be used in future in vivo. 
 
Our laboratory has already demonstrated the advantages and the successful 
applications of silica nanocomposite based polyurethanes in producing 
vascular tissue engineered grafts, such as improved cell adhesion 
characteristics using a silicon pendant nanocage (Kannan et al. 2005). In 
this study we assessed whether similar, although biodegradable, 
nanocomposite POSS-PCL was safe and compatible with in vitro cell 
cultures when intestinal epithelial cells were employed. Another aim of this 
study was to suggest suitability of alternative biodegradable polymers like 
POSS-PCL for soft tissue engineering, as opposed to the widely accepted 
sole use of PGA/PLLA copolymers in small intestinal tissue engineering. 
PCL in our experience has been less expensive, and easily dissolvable in 
commonly available organic solvents unlike PGA which is very hard in 
consistency and requires highly fluorinated solvents such as 
hexafluoroisopropanol. Poly ( -caprolactone), –[(CH2)5–COO]n–, is a 
synthetic biodegradable polyester which has been widely used in controlled-
release drug formulations. It has the advantage of leading to neutral 
degradation products which is in contrast to the acidic degradation products 
of other commonly used biodegradable polymers such as poly(lactide-co-
glycolyde) (PLGA) and polylactic acid (PLA). Another feature of PCL is its 
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slower degradation rate that may be advantageous in applications that 
require prolonged release times. Our nanocomposite maintains mechanical 
stability due to nanocages while simultaneously allowing controlled 
degradation. In this study, we used mainly two pore sizes – 150-250 µm and 
< 100 µm. Apart from the pore size, we also used two different porosities, 
one in the range of 80% and the other in the range of 40%. Solvent casting 
and salt leaching resulted in the production of scaffolds with pore size and 
porosity in the desired range. The pores were interconnected as can be seen 
on SEM and micro CT. In this study, we assessed the suitability of cell 
growth on this polymer. All the samples supported cell viability and 
proliferation and a confluent layer of cell growth was seen on SEM in all 
samples of seeded cells. We used two dimensional scaffolds in this study. In 
a three dimensional scaffold, a larger porosity is more like to positively affect 
the overall cell growth especially within the deeper layers of the scaffold.  
 
In this study, the approximate cell size was much smaller than the organoid 
unit employed in the previously mentioned rat studies. The results of cell 
growth were not better in scaffolds of pore size in the range of 150-250 µm 
than those in the range of <100µm. Rather the later group showed slightly 
better proliferation than the former. It is assumed that if much larger pore 
size is used as compared to the cell size, a number of cells may fail to attach 
when seeded. In the scaffold of mixed porosity, results of cell growth were 
not significantly different from the ones with either microporous or 
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macroporous structure alone. IEC proliferation was followed for 21 days on 
scaffolds made of high and low porosity; and, large and small pore size. All 
samples examined were able to support both initial cell seeding and 
prolonged cell growth over the course of the 21 days investigated. Studies of 
LDH levels demonstrated that there was little initial cell damage. There was 
no significant difference in cell seeding or growth between any of the 
samples investigated. These findings were confirmed by the SEM studies 
which demonstrated cells present on all samples at Day 21. The potential of 
the POSS-PCL scaffold to support cell seeding and growth was therefore 
confirmed. 
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Chapter 8: Discussion 
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Short bowel syndrome (SBS) is a condition of nutritional malabsorption 
related to the surgical removal or disease of a large portion of the small 
intestine. It is generally believed that a loss of more than 70% small intestine 
causes SBS, which is characterised by diarrhoea, steatorrhoea, severe 
weight loss, malnutrition, and eventually failure to thrive resulting in a high 
incidence of mortality both in children and adults. The mainstay of treatment 
of SBS remains to improve the nutritional status of the patients by enteral 
(EN) or parenteral (PN) feeding. Home parenteral nutrition (HPN) has been 
used as a life-saving treatment for patients with intestinal failure. Other 
methods to treat SBS include surgical procedures like sequential intestinal 
loop lengthening. For patients dependent on PN, intestinal transplantation is 
the last hope in the present medical field. However, high mortality rates of 
about 50% as well as shortage of donor organs limits intestinal 
transplantation to progress rapidly. An off-the-shelf artificial intestine would 
definitely prove to be a novel therapy for patients with SBS. Attempts have 
been made to engineer small intestine, as a definitive solution to the 
complex problem of SBS, since 1998. In our published review (Gupta et al. 
2006); we have highlighted the major advances done so far in this field. 
Vacanti et al have employed rat’s intestinal epithelial organoid units as the 
cell source to be seeded onto porous synthetic biodegradable polymer 
scaffolds made of Polyglycolic acid (PGA) or copolymer poly(lactic-co-
glycolic acid) (PLGA) and achieved considerable success in regenerating 
neointestinal tissue. Their laboratory was the first to report in 1997, 
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developing tissue engineered small intestine, in form of cysts having 
intestinal neomucosa, by the transplantation of organoid units on a polymer 
scaffold into the omentum of the Lewis rat (Choi & Vacanti 1997). These 
intestinal epithelial organoid units were isolated from neonatal rats as per the 
method first developed by Evans et al in 1992(Evans et al. 1992). Intestinal 
epithelial organoid units are multicellular units derived from neonatal rat 
intestine, containing a mesenchymal core surrounded by a polarized 
intestinal epithelium (Takezawa 2003), and contain all of the cells of a full-
thickness intestinal section (Evans et al. 1992;Weiser 1973). These studies 
used highly porous, synthetic, biodegradable polymer tubes as scaffolds, 
fabricated from nonwoven sheets of polyglycolic acid (PGA) fibres [with or 
without coating of poly(L-lactic acid) (PLLA)], with a fibre diameter of 5 µm, 
mesh thickness of 2 mm, bulk density of 60 mg/cm3, porosity of 95% and a 
mean pore size of 250 µm.  
 
Apart from the above experimental model in rats where organoid units-
polymer constructs have been implanted in rat’s omentum for neo-intestinal 
tissue generation, other research groups have used different methods in 
different animal models aiming towards the same goal. Some have done 
experiments in dogs when they used ‘acellular’ collagen sponge scaffold 
grafting with a silicon tube stent sutured in place of 5 cm intestinal defect 
(Hori et al. 2002), and some have used porcine small intestinal submucosa 
(SIS) as a natural scaffold replacing jejunal defects in rabbits (Demirbilek et 
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al. 2003). Such experiments were done based on the principle of cell 
migration from adjacent healthy intestinal epithelium, however were limited in 
their success by lack of muscle layer, contraction of graft, and by 
unlikelihood of similar cell migration if much longer defects in intestine had to 
be replaced with a scaffold tube. 
 
So far in most of the studies investigating small intestinal tissue engineering, 
the main polymer used to fabricate scaffolds has been polyglycolic acid 
(PGA) or poly(L-lactic acid) (PLLA), or copolymer poly(lactic-co-glycolic acid) 
(PLGA). The main reason behind their predominant use appears to be firstly, 
that vast of the studies conducted in this topic has been done by only one 
group of scientists from University of Massachusetts (Gardner-Thorpe et al. 
2003;Grikscheit et al. 2004;Kaihara et al. 1999;Kim et al. 1999c;Vacanti et al.  
1988), and secondly, that they are easily commercially available as porous 
non-woven sheets from the market. Investigating tissue engineering of small 
intestine still remains in its infancy and is a continually evolving subject. 
However, other polymers like polycaprolactone have not been investigated, 
in vitro or in vivo. PGA or PLLA are biodegradable, thermoplastic aliphatic 
polyesters. PLLA has a crystallinity of around 37%, a glass transition 
temperature between 50-80 °C and a melting temperature between 173-
178 °C. PGA has a glass transition temperature between 35-40 °C and its 
melting point is reported to be in the range of 225-230 °C. PGA has a 
crystallanity of around 45-55%, thus rendering insoluble in water. In our 
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experience, PGA is a very stiff polymer and insoluble in commonly available 
organic solvents due to its high molecular weight. It is only soluble in 
selective highly fluorinated solvents like hexafluoroisopropanol. 
 
For some years now, concept of nanocomposites have evolved where one of 
the phases has one, two, or three dimensions of less than 100 nanometers 
or structures having nano-scale repeat distances between the different 
phases that make up the material (Ajayan et al. 2003;Kannan et al. 2005). 
The main advantage of nanocomposites over conventional polymers is the 
high surface to volume ratio of nanoparticulates resulting in better physical 
properties and higher performance than the original matrix.  
 
Our laboratory has developed a biodegradable nanocomposite by 
incorporating the biostable polyhedral oligomeric silsesquixane (POSS) 
nanocages into a poly(caprolactone/carbonate)urethane urea. Our 
nanocomposite is a polyurethane which has a soft segment composed of 
polycaprolactone (80%) and polycarbonate (20%), and hard segment 
composed of urea. The polymer is approximately 22% by wt hard segment. 
Eighty percentage of polycaprolactone diol (mwt) was considered an 
appropriate initial formula for use as a tissue engineering scaffold for small 
intestine or cartilage. Such a scaffold would be required to maintain its 
structural integrity for at least 4–6 months (Raghunath et al. 2008). PCL is 
relatively slow to degrade as compared to PGA or PLLA, which is an added 
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advantage in tissue engineering of soft structure like small intestine where a 
slow degradation is required over a period of few months rather than weeks. 
It is proposed that caprolactone will provide controlled degradation whilst the 
POSS nanocages will contribute to the mechanical strength required for a 
tissue engineering scaffold for soft tissue such as small intestine. 
 
Dental composites containing polyhedral oligomeric silsesquioxanes (POSS) 
were found to possess improved flexural strength and Young’s modulus 
(Fong et al. 2005). POSS can be incorporated into the hard segment of 
polyurethane as a pendant side chain. Studies using an octahedral dimeric 
silsesquioxane in polycarbonate polyurethanes have shown excellent 
biocompatibility such as cell viability in vitro and the absence of inflammation 
or capsule formation in vivo (Kannan et al. 2005;Kannan et al. 2006a). 
Therefore, it is proposed that a biodegradable form of this generation of 
polyurethane might be an ideal choice as a tissue engineering scaffold for 
soft tissue. Polycaprolactone is degradable aliphatic polyester which has 
been extensively reported to demonstrate biocompatibility in vivo. Its 
degradation by hydrolysis and enzymes is well documented. PCL has been 
used in several copolymers and polymer blends as the foundation to a tailor-
made polymer with specific properties (Raghunath et al. 2008). 
 
In vivo host response of POSS-PCL has not been studied but POSS-PCU 
(poly(carbonate)urethane urea), the nonbiodegradable counterpart lacking 
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polycaprolactone, made by the same group, was implanted in sheep for 36 
months and showed only minimal inflammation as compared to silicone 
implants (Kannan et al. 2007). 
 
This composite has been tested for degradation in a separate study 
(Raghunath et al. 2008) where the nanocomposite (POSS-PCL) was 
exposed to a selection of accelerated degradative solutions for up to 8 
weeks. Degradation of hard and soft segments of the nanocomposite was 
evident by infra-red spectroscopy in all conditioned samples. POSS 
nanocage degradation was evident in some oxidative/peroxidative systems 
accompanied by gross changes in surface topography and significant 
changes in mechanical properties. The hydrophobic polymer became more 
hydrophilic in all conditions. This biodegradable nanocomposite 
demonstrated steady degradation with protection of mechanical properties 
when exposed to hydrolytic enzymes and plasma protein fractions and 
exhibited more dramatic degradation by oxidation. 
POSS-PCU, the non-degradable counterpart made and patented by our 
laboratory showed considerable success in vascular tissue engineering 
when scaffolds for microvascular grafts (Sarkar et al. 2009b), heart valves 
(Kidane et al. 2009) and aortic stent (Bakhshi et al. 2009) were attempted.  
Our aim in this work was to investigate characteristics of POSS-PCL, the 
biodegradable nanocomposite in view of fabricating porous scaffolds for use 
in small intestinal tissue engineering. We aimed at studying the polymer’s 
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processibility into porous scaffolds, its physical properties, mechanical 
strength, degradation, biocompatibility and cytocompatibility.  
 
In our first experimental chapter, we used solvent casting/particulate 
leaching technique to fabricate 2 mm thick sheets of porous scaffolds from 
POSS-PCL. Scaffolds were obtained in two pore size ranges of 150-250 
microns (macroporus) and <150 microns (microporous), and two porosities 
of 80 and 40 percents. This was achieved by using different salt sizes and 
salt concentrations in each sample. Both salt sizes were mixed in one of the 
samples to obtain a mixed pore sized sample. Control sample was prepared 
without any salt in it. The porosities obtained by calculations as per the 
formula were in accordance to the percentage of the salt particles used. For 
example, in sample 1, we used 80% salt by weight, and the mean porosity 
obtained was 83.9±0.5. 
 
Scanning electron microscopy showed spherical pores and pore-pore 
interconnectivity. The pore size was in the expected range as per the size of 
salt particle. Further pore morphology and interconnectivity was studied 
using micro CT.  
 
Micro-CT has an advantage of non-destructiveness and 3D image analysis 
including structural measurement. There is no need for extensive sample 
preparation, and three-dimensional information can be obtained at high 
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spatial resolution. The results of Micro CT confirmed the porosity calculated 
by using simple formulae. A mean value from 100 sections of the sample 1 
was found to be 80% ± 2%, and the pore size varied from 140-250 µm, as 
expected from the polymer-salt ratios. Good pore interconnectivity was seen 
in the sample studied. 
 
Mechanical tests were performed in uniaxial tension on a tensometer. 
Stress-strain relationships were obtained for the samples and graphs were 
plotted. The porous scaffolds were found to be much less stiff as compared 
to the nonporous sample. In other words, increasing porosity resulted in 
decreasing strength of the scaffold. Pore size had no significant influence on 
stress strain patterns.  
 
Infrared spectra of a porous and nonporous scaffold were recorded on a 
FTIR spectrometer and the results showed that the basic structure of 
scaffold remained preserved after particulate leaching. 
 
POSS-PCL was successfully able to be fabricated in highly porous sheets of 
scaffolds with pore sizes in the desired range, using a simple and 
inexpensive technique of solvent casting/ particulate leaching. Increasing 
porosity was found to reduce the strength of scaffolds. Pore-pore 
interconnectivity was achieved as seen on SEM and micro CT. The basic 
structure of the scaffold as in the control sample was preserved after solvent 
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casting/ particulate leaching as seen in FTIR.  
 
In the second experimental chapter, we subjected POSS-PCL to 
electrospraying, electrospinning, and electroprinting. Electrohydrodynamic 
jetting is a process where a liquid medium forms a jet and breaks into 
droplets as it is released at a controlled flow rate through a needle while 
being exposed to an electric field caused by the existence of a potential 
difference between the needle and a ground electrode. We achieved this 
with biopolymers in this experimental work and to the best of our knowledge; 
this was the first time electrohydrodynamic printing was used to prepare 
scaffolds for tissue engineering, and was published (Gupta et al. 2007). One 
advantage of electrohydrodynamic printing over ink-jet printing is that much 
larger sized nozzles used (750 µm in this work) prevent needle-blockages 
allowing easier processing of the viscous polymer solutions to finer 
dimensions. 
 
Initial print-patterning results showed discontinuities in the scaffolds 
prepared from both polymers. This problem was overcome with the careful 
adjustment of the distance between the needle tip and the glass slide; 
however, the printed structures could not be peeled-off from the glass 
substrate. When polymer was printed onto ethanol kept on the glass slide, 
instant precipitation of the polymer deposits occurred. Printing on to ethanol 
was much smoother with stable jetting. A few discontinuities were seen in 
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the scaffolds prepared and these were caused by unstable jetting probably 
caused by variations of flow rate. Microscopy of the scaffolds prepared 
showed that a wavy and coil-like pattern prevailed when polymer was 
deposited on to ethanol. Moreover, single layer prints with or without ethanol 
on the glass slides were fragile and did not sustain their structure when 
peeled off the substrate. When overprinting was performed five times in the 
presence of ethanol, the resultant scaffold could be peeled-off the glass slide 
and sustained its structure.  
 
In this study we printed two grid patterns – a smaller grid (window size 
250µm) and a larger grid (window size 500 µm). As seen in scanning 
electron micrographs, the samples were macroporous with a reduction of 
window size by ~ 30-100µm than the designed levels corresponding to the 
size of the polymer strand forming the window. Another factor affecting 
smaller than expected window size could be the shrinkage of the scaffold 
due to drying after printing.  
 
The coiled appearance of the polymers printed on ethanol may be attributed 
to the instant precipitation of the polymer solution in ethanol. Selecting a 
liquid medium where precipitation of the polymer is more controlled can be 
important. Polymer deposits printed directly on the glass slide without 
ethanol were seen to be straight or wavy but not coiled. When ethanol was 
used as a layer of substrate over glass slide, this distance had to be 
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increased to ~1.5mm in order to avoid spreading of the polymer threads 
away from the main printed line. Also, with ethanol present, the optimum 
voltage for smooth continuous was found to be slightly higher, in the range of 
9.1-10.0. This change could be attributed to an increased electric force 
required for the polymeric threads to precipitate through ethanol onto the 
glass slide, and for a higher voltage required to atomise the more viscous 
biodegradable polymer.  
 
In summary, this was an attempt to print polymer solutions into a pre-
designed structure of a scaffold for tissue engineering using 
electrohydrodynamic technology. Prints on ethanol resulted in almost 
instantaneous precipitation of the polymer facilitating peeling off the scaffold 
from the substrate. Scanning electron microscopy of the peeled scaffolds 
revealed a macroporous structure with polymer strands of diameter 15-50 
µm. The polymer strand diameter was found to be dependent on the 
distance between the needle exit and the substrate, the voltage applied and 
the viscosity of the polymer solution.  
 
One of the limitations of our experiments was the inability to obtain 0.5-1 mm 
thick scaffolds because over-printing could not be carried out more than five 
times in the z direction. Hence these scaffolds could not be tested for in vitro 
cell compatibility tests. This was directly related to the flow rate of the 
polymer from the needle. The best scaffolds were obtained when a drop of 
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polymer was manually pushed to the tip of the needle and atomised. This 
quantity was sufficient to over-print five times, after which the polymer at the 
tip of the needle solidified due to evaporation of solvent. More than the 
optimal amount of polymer solution required for atomisation was delivered 
even at a minimum infusion rate of 1 µl/hour of the pump used, making 
“blobs” of polymer deposit on the scaffolds. This limitation may be overcome 
by refining the flow rate using better and finer adjustable infusion in future.  
 
In experimental chapter 7, in vitro tests were conducted to assess cyto-
compatibility of POSS-PCL scaffolds when rats’ intestinal epithelial cells 
were cultured onto them. Our aim was to test the cell viability and cell 
proliferation when grown on scaffolds as substrates of different porosities 
and different pore sizes. We also aimed at optimising the number of cells 
required to be seeded before a confluent cell growth could be achieved. 
Discs of polymer samples were seeded with rat small intestine epithelial cells 
at a concentration of 2.5 x 106 cells per well in 1 ml cell culture medium. 
Cells were allowed to attach for 24 hours after which the medium containing 
unattached cells was removed for lactate dehydrogenase (LDH) analysis to 
assess initial cell damage. The seeded polymer discs were then transferred 
to a fresh 24 well plate (to avoid the possibility of measuring cells seeded 
onto the initial well bottom during the seeding process) and cell metabolism 
assessed using an Alamar BlueTM assay. Cell metabolism was then further 
measured at days 3, 6, 10, 14 and 21 post initial seeding. Samples of 
seeded polymer were also taken for analysis by scanning electron 
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microscopy at Day 21 as above. 
 
LDH release was examined to look at potential cell damage in the initial 
seeding period. The differences in LDH levels were actually quite small 
compared to the levels from the tissue culture plastic seeded cells indicating 
that little initial cell damage has occurred. When statistical analysis was 
carried out on the levels for the scaffold samples there was in fact no 
significant difference (p > 0.05) between the scaffold samples and positive 
control.  
 
The results obtained from the investigation of cell growth and metabolism of 
IEC cells seeded on the various polymer samples demonstrated that cell 
growth occurred over the course of the 21 day study. All polymer samples 
showed a significant reduction in cell metabolism compared to the positive 
control (as anticipated, tissue culture plastic being optimal for cell growth). 
However cell growth occurred on each polymer sample over the whole 21 
day period suggesting a slower growth rate compared to tissue culture 
plastic. There was no significant difference between any of the polymers of 
different pore sizes or porosities, examined over the time period 
investigated. No further data was collected after 21 days growth as we 
believed that this was a reasonable period to demonstrate successful cell 
growth on the scaffolds and wished to collect samples for SEM analysis at 
this point. The cells grew at a reasonably steady rate over this time period 
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and the SEM pictures demonstrate that they were approaching confluence at 
this point. 
  
These findings however did not testify the belief that higher porosity samples 
should have better cell proliferation. In this study, the approximate cell size 
was much smaller than the organoid unit employed in the previously 
mentioned rat studies. It is assumed that if much larger pore size is used as 
compared to the cell size, a number of cells may fall through the pores when 
seeding. In the scaffold of mixed porosity, results of cell growth were not 
significantly different from the ones with either microporous or macroporous 
structure alone.  
 
We have developed these porous scaffolds from a relatively new and 
successful nanocomposite POSS-PCL. In future studies, these scaffolds 
need to be tested in vivo. One of the options remains using the technique by 
Vacanti et al where these scaffolds can be seeded with juvenile rats’ 
intestinal epithelial organoid units and then implanted in rats’ omentum. The 
cysts thus generated can then be be anastomosed to the intestine. The other 
option can be a direct anastomosis to an isolated segment of intestine and 
assess cell growth based mainly on the principles of cell migration from the 
adjacent native mucosa. This is due to remarkable regenerative capability of 
intestinal mucosa. However both the above options have their limitations. 
The entire intestinal length of 40 neonatal rats was required to make 
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organoid unit-polymer constructs sufficient to implant in 10 adult rats. The 
question of availability of human neonatal intestine in such large amounts 
seems to be one of the limiting factors. Moreover, it is not clear whether the 
absorptive capacity is improved through the anastomosed segment of tissue 
engineered small intestine (TESI) because of added mucosal surface area or 
whether it is due to slow transit. In the other option, cell migration is believed 
to occur only for a short distance and appears not practical when a large 
absorptive surface is required to compensate for the losses from short bowel 
syndrome. Furthermore, peristalsis in a neo-intestine will always remain an 
obstacle, as generation of muscle layer with nerves is unlikely to occur.  
 
Despite these obstacles, tissue engineering of small intestine remains a 
clinically viable option which can prove to be a life saving promise to the 
suffering patients with short bowel syndrome. However this would require 
years of continuing efforts from researchers. One of the feasible options to 
overcome the main hurdle of cell source will be to isolate stem cell which can 
be linked with biomolecules or cues towards an intestinal lineage. That can 
prove to be a holy grail. A better understanding of cell-cell and cell-ECM 
interactions, specific stem cell markers, trophic growth factors, and bioactive 
scaffolds is required. We hope to scrutinize porous scaffolds developed in 
this work from a relatively new nanocomposite as a step forward in this 
complex field of tissue engineering. 
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Conclusion and Future Recommendations 
 
 
Nanocomposite polymers are the new generation polymers which have 
shown advantages over the conventionally used polymers due to high 
surface to volume ratio of nanoparticulates resulting in better physical 
properties and higher performance than the original matrix.  After successful 
applications of nondegradable POSS-PCU developed and patented by our 
laboratory in vascular tissue engineering, POSS was incorporated in 
biodegradable polymer PCL to develop relatively new nanocomposite 
POSS-PCL for investigating tissue engineering soft structures like small 
intestine. POSS-PCL can be successfully subjected to a novel technique of 
electrohydrodynamic printing which results in desired pore morphology and 
fibre diameter, however the optimum thickness of 2-3 mm will be difficult to 
achieve unless much refined machinery is available to control the flow of 
polymer solution through the needle in an electric field. The same 
nanocomposite when fabricated using solvent casting/ particulate leaching 
results in scaffolds with desired porosity, pore size, and pore morphology. 
When seeded with rats’ intestinal epithelial cells in vitro, POSS-PCL 
scaffolds allow cells to remain viable and proliferate.  
 
In future POSS-PCL scaffolds needs to be scrutinized in vivo in animal 
models ideally with stem cells if they can be cued to intestinal lineage. One 
of the relatively recent advances in successfully identifying stem cells in 
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small intestine and colon by marker gene Lgr5 may prove to be a vital step in 
isolating intestinal specific stem cells from the crypts of small intestine 
(Barker et al. 2007). Lgr5 (leucine-rich-repeat-containing G-protein-coupled 
receptor 5) is a gene selected from intestinal Wnt target genes. 
 
Tissue engineering of small intestine despite some obstacles remains a 
clinically viable option which will requires years of research and development. 
POSS-PCL scaffolds developed in this study can prove to be a vital step 
forward as a fresh impetus in the complex field of tissue engineering. 
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